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Research Experience for Undergraduates
University of Arkansas
The University of Arkansas Department of Chemistry and Biochemistry hosted a
National Science Foundation sponsored Research Experience for Undergraduates (REU) summer
program for the 21st year. The department first hosted an REU in 1959. The 10-week summer
program, funded by the National Science Foundation, allowed students an opportunity to gain
hands-on experience in a chosen research area while introducing them to careers in scientific
research in areas including analytical chemistry and sensor technology, biochemistry and protein
dynamics, inorganic chemistry and nanotechnology, organic chemistry, and physical and
theoretical chemistry.
Undergraduate chemistry majors, who were sophomores or juniors in fall 2009, applied
to the program, which took place in the Ozark Mountain Plateau.
Outside the lab, students met each week to hear presentations from campus experts about
topics ranging from how to get into graduate school and test-taking skills to ethics, and how to
make a poster presentation. A number of social activities took place throughout the summer to
give students a chance to interact.
Selected students received a scholarship to pay for room and board and an allowance to
attend a regional or national chemical conference in the 2010-2011 academic year. Students
involved in the program were enrolled as students at the U of A and received one hour of
research credit. The program was conducted from May 16, 2009 to July 23, 2009.
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Tony Jude Award
Arkansas native Vernon (D.J.) Crowell was the recipient of the Tony Jude Award for his
summer research. He is a student at Lyon College. The Tony Judy Award was created in 2002
to recognize a student for outstanding research. It is awarded in memory of a former REU
student who returned to the University of Arkansas and obtained a doctorate degree.
D.J., under the direction of Distinguished Professor Peter Pulay, presented a poster
entitled “Computer Modeling of the Thermal Rearrangement of 2-aryl-2H-azirines to Indoles.”
He is pictured below with Distinguished Professor Peter Pulay and Program Co-Director
Professor David Paul.
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2010 REU Participants
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Faculty Project List
Paul Adams
Assistant Professor

Biophysical Characterization of Proteins Associated with Signal
Transduction

Neil Allison
Associate Professor and ViceChair

Synthesis and Chemistry of Potential Organometallic Anticancer
Drugs

Dan Davis
Professor

Protein-Protein Interactions in Phogosynthesis: Structure-Function
Relationships in Electron Transfer Proteins

Ingrid Fritsch
Professor

Microelectrochemical Detection and Microfluidics for Lab-on-achip Applications: Protein, DNA, and Microorganism Analysis

Bob Gawley
Distinguished Professor

Synthetic and Mechanistic Organ(ometall)ic Chemistry

Denise Greathouse
Research Assistant Professor

Characterization of Structure and Peptide-Lipid Interactions of
Membrane Active Antimicrobial Peptides

Colin Heyes
Assistant Professor

Development of Nanocrystals for Biophysical Applications

Roger Koeppe
University Professor

Biophysical Studies of Single-Span Transmembrane Proteins and
Membrane Channel Gating

T.K.S. Kumar
Assistant Professor

Structure, Dynamics, Folding and Interactions of Proteins

Matt McIntosh
Associate Professor

Total Synthesis of Biomedically Significant Complex Natural
Products

Frank Millett
Distinguished Professor

Biological Electron Transfer

David Paul
Associate Professor

Development of chemical Sensors for Clinical and Environmental
Applications

Peter Pulay
Distinguished Professor

Ab initio Calculation of the Vibrational and NMR Spectra of
Protein Models

Joshua Sakon
Associate Professor

Structure and Function of Drug-Targets

Derek Sears
University Professor

Cosmochemistry
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Julie Stenken
Professor

Measurement of chemical Communication (Signaling) Molecules,
e.g., Cytokines, Neuropeptides, etc., Biosensors, or In Vivo
Chemical Analysis

Wesley Stites
Professor

Exploring the Influence of the Denatured State upon Protein
Stability, -or- Isolation, Characterization, and Impact upon Blood
Clotting of Human Thrombomodulin in Disease

Z. Ryan Tian
Assistant Professor

Syntheses and Applications of Ordered and Complex
Nanostructures

Charles Wilkins
Distinguished Professor

Matrix-assisted Laser Desorption Fourier Transform Mass
Spectrometry for Whole-cell Bacteria and Polymer Analysis

Nan Zheng
Assistant Professor

Natural Product Synthesis, Metod Development, and
Organometallics
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UNIVERSITY OF ARKANSAS
NSF – CHEMISTRY – REU - SUMMER 2010
Activities and Events
Sunday, May 16
1:00 p.m. – 4:00 p.m.

Arrival, Check-In & Registration
Maple Hill West (front desk: (479)718-2590)

6:00 p.m. – 9:00 p.m.

Monday, May 17
7:00 a.m. – 8:30 a.m.

Welcome Dinner
University House, Whole Hog Barbeque

Breakfast
Quad Dining Room

8:45 a.m.

Meet in quad lobby to go to university together

9:00 a.m. – 10:00 a.m.

Group Photo
Front of Library

9:45 a.m. – 11:45 a.m.

Campus Logistics (Concurrent Sessions)

RED
YELLOW

Session I: 9:45-10:30 a.m.
Session II: 9:45-10:30 a.m.

Session II: 10:45-11:30 a.m. (Carver & MEEG)
Session I: 10:45-11:30 a.m. (CHEM, Phys, & Food Sci)

Session I:

Cash Checks, ID Cards Issued
Arkansas Union
Parking and Transit available: $21.57 per parking
tag.
May park in lot 41 (near Reid Hall) Monday. Tag
needs to be displayed by Tuesday to avoid ticketing.
Session II: Library Orientation
University of Arkansas Mullins Library

12:00 p.m. - 1:30 p.m.

Opening Luncheon
Place: Student Union Ballroom
Speaker: Dr. Donald Pederson, Vice Chancellor, Professor
of Physics

1:30 p.m. – 2:30 p.m.

Campus Tour
Meet in Ballroom with campus ambassadors

2:30 p.m. – 4:30 p.m.

Departmental Logistics
Place: Chemistry Building Room 105
Meet your Mentor: Refreshments will be served
Get Keys, Take Photos
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Tuesday, May 18
8:00 a.m. – 10:00 a.m.

Safety Briefing: Bill Durham, Department Chair
CHEM 105

11:00 a.m. – 12:00 a.m.

CHEMISTRY Library Tour
Place: MULLINS 102, moving to CHEM Library
Librarian: Luti Salisbury

12:00 noon

Go to Your Lab and Get Started!

Wednesday, May 19
8:00 a.m.

Report to your lab

5:30 p.m. – 7:00 p.m.

Dinner & Dialogue
Place: Alumni House
Speaker: Dr. Dennis Brewer, Assoc. Vice Provost for
Research
Topic: Research and Ethics

Friday, May 21
1:00 p.m.

REU Meeting
CHEM 105
Speaker: Professor Julie Stenken
Topic: Why is in vivo Glucose Sensing so Challenging?

Wednesday, May 26
5:30 p.m. – 7:00 p.m.

Dinner & Dialogue
Place: Donald W. Reynolds Center, Seminar Room A
Speaker: Dr. Collis Geren, Dean of the Graduate School
Topic: Little Brown Spider

Thursday, May 27
6:00 p.m. – 9:00 p.m.

Evening Entertainment
Host: Chemistry
Location: Devil’s Den State Park (bring swim suit!)

Friday, May 28
1:00 p.m.

REU Meeting
CHEM 105
Speaker: Dr. Robert Gawley
Title: Why did Alice say to Kitty: “Perhaps looking glass milk
isn’t good to drink.” A guided tour from Lineland to
Spaceland.

Saturday, May 29– Monday May 31 Free for Memorial Day Weekend
Wednesday, June 2
5:30 p.m. – 7:00 p.m.

Dinner & Dialogue
Location: Alumni House
Speaker: Lynn Meade
Topic: How to Give an Effective Presentation
7

Thursday, June 3
6:00 p.m. – 9:00 p.m.

Evening Entertainment
Host: Carver
Location: Starlight Skatium

Friday, June 4
1:00 p.m.

REU Meeting
CHEM 105
Speaker: Dr. Paul Adams
Title: Protein Purification

Wednesday, June 9
5:30 p.m. – 7:00 p.m.

Dinner & Dialogue
Place: Donald W. Reynolds Center, Seminar Room A
Speaker: Dr. Alex Lostetter
Topic: Science Careers

Thursday, June 10

Evening Entertainment
Host: Physics
Location: Movie Night

Friday, June 11
1:00 p.m.

REU Meeting
CHEM 105
Speaker: Professor Lothar Schäfer
Title: Science and Divine Reality

Monday, June 14

Canoe Trip

Wednesday, June 16
5:30 p.m. – 7:00 p.m.

Dinner & Dialogue
Place: Donald W. Reynolds Center, Seminar Room A
Speaker: Shani Farr & Vicky Hartwell
Topic: Applying to Grad School and Funding your Graduate

Degree
Thursday, June 17
6:00 p.m. – 9:00 p.m.

Evening Entertainment
Host: Mechanical Engineering
Location: Ozark Lanes

Friday, June 18
1:00 p.m.

REU Meeting
CHEM 105
Speaker: Prof. Jack Lay
Topic: Mass Spectrometry and Biomarkers

Saturday, June 19
10 a.m.

Practice GRE and GMAT test offered
Testing is FREE
Participation requires pre-registration
Location: Maple Hill South, Room 145
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Thursday, June 24

Evening Entertainment
Host: Micro EP
Location: Veteran’s Park, Lake Fayetteville

Friday, June 25
1:00 p.m.

REU Meeting
CHEM 105
Half-way Progress Report Presentation
Progress Reports Due

Monday-Tuesday, June 28-29
NCTR Tour
Jefferson, AR
Overnight stay in Little Rock, Dinner w/ INBRE students
Friday, July 2
1:00 p.m.

REU Meeting
CHEM 105
Speaker: Professor T.K.S. Kumar
Topic: The Biochemistry of Molecules that Sustain Life

Saturday, July 3 – Monday, July 5 Free for Independence Day Weekend
You must return to Fayetteville by 8:00 a.m., July 6
Wednesday, July 7
3:00p.m. – 7:00 p.m.

Final Carver Presentations

Friday, July 9
1:00 p.m.

REU Meeting
CHEM 105
Speaker: Dr. Colin Heyes
Topic: Nanochemistry and biochemistry at the single
molecule level

Friday, July 16
1:00 p.m.

REU Meeting
Chem 105
How to Make a Poster
David Paul

Thursday, July 22
10:00 a.m.

Meeting in Miniature, Lunch Served
CHEM 105

Friday, July 23
5:00 p.m.

End of Program
Final reports due
Dorm check-out

Saturday, July 24
By 11:00 a.m.

End of Program
Get out of the Dorm, last check-out
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Analysis of [6,6]-phenyl C61 butyric acid methyl ester (PCBM) by FTMS
Eric Berget, Minnesota State University Moorhead
Moorhead, MN

Abstract
An analysis of [6,6]-phenyl C61 butyric acid methyl ester (PCBM) was conducted to
determine the optimal characteristics for obtaining reference spectra with the least amount
of fragmentation. The characteristics varied were matrix to analyte ratios, laser power
influence, sample deposition methodology, and solvents used. The analysis of PCBM was
also compared between two different ionization process, laser desorption ionization (LDI)
and matrix assisted laser desorption ionization (MALDI). Following ionization the ions
were analyzed by Fourier Transform Mass Spectrometry (FTMS). Electron transfer
matrices dithranol and 9-nitranthracene were used in the analysis, in combination with the
solvents chlorobenzene and toluene.

Introduction
The purpose of experimentation:
The fullerene PCBM is most notably used in combination with poly(3-hexylthiophene)
(P3HT) for use in organic heterojuction photovoltaic cells (1,2). Due to the rising demand for
energy, organic heterojuction photovoltaic cells are being explored as an alternative to the
current silicon based solar cells. However, the PCBM/P3HT heterojuction cells undergo
degradation when in service. Mass spectrometry could be used at set intervals of the degradation
process to study the mass and ascertain the type of chemical reactions that are occurring and the
resulting product. However, reference spectra must be obtained of the starting materials; so that
the differences noticed in the degraded solar cells can be linked to the degradation process. The
focus of this experiment is to obtain reference spectra for PCBM and determine the optimal
parameters for its analysis by MALDI.
The ionization processes MALDI and LDI:
The analysis on PCBM was conducted using LDI and MALDI as the ionization process
in combination with FTMS as the analyzer. The ionization process LDI consists of a laser
striking an analyte on a target plate and causing ionization by departing energy on to it. The
direct transfer of energy to the analyte and subsequent reactions in the ion plume cause
ionization and fragmentation (3,4). The target plate is responsible for housing the sample to be
studied and can be made of anything from stainless steel to Teflon (5). The ion plume is an area
or “cloud” where ionization processes occur and other various reactions (6,4). The ion plume is
an area of intense research and to date there are various theories, but no clear understanding of it
(6).
The implementation of matrix in MALDI causes reduced fragmentation and an increased
parent ion concentration in relation to LDI. MADLI is similar to LDI in that a laser strikes the
analyte, but with a certain ratio of matrix mixed in. MALDI is the optimal soft ionization process
for larger molecules due to large amounts of fragmentation with LDI. Smaller molecules,
however, can be studied for the most part effectively using LDI which is considerably less time
consuming in comparison to MALDI. The reason is because MADLI has many variables to
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consider and to date no default matrix or solvent has been found (7). Therefore, several trail
experiments must be done to obtain the best possible result. The known variables that can affect
MALDI are the matrix to analyte ratio, solvent used, target plate material, laser type/power, and
type of application process to the target plate (5,3,4).
However, unlike in LDI, the analyte does not receive all the blunt force of the transferred
energy from the striking laser beam, and instead the energy is transferred to the matrix and
subsequently to the analyte by a series of reactions. The type of ionization process that the
analyte undergoes depends on the type of matrix that is employed (3). The analyte can be ionized
by the addition of hydrogen, the removal of an electron, or the addition of an electron. The
ionization process can happen at the surface by contact with the laser beam or through reactions
in the ion plume.
Fourier Transform Mass Spectrometry:
Once the ionization process is complete the ions must be transferred to the mass analyzer
which in this case is the FTMS. The ions can are transferred by means of ion guides (3). The ions
are detected in the FTMS in what is called an ion cyclotron resonance (ICR) cell. The ions
generate a cyclotron frequency as they orbit about the cell, which causes an image current to be
generated (3). The image current is fleeting at one location and moves around the cell as the ions
orbit inside (3). However, the image current can be detected and through a mathematical process
called the Fourier Transform a mass spectrum can be generated that reflects that ion. Therefore, a
typical mass spectrum that contains several different types of ions is actually the detection of
several image currents and subsequent Fourier transforms. The lower detection limit of FTMS,
however, still requires several thousand ions to hundreds of thousands of ions present to be
detected and give an associated ion peak.
Choice of Matrices and Optimization of MALDI for PCBM Analysis:
The matrices used in the analysis of PCBM by MALDI-FTMS are dithranol and 9nitroanthracene. Dithranol is a very commonly used matrix for the analysis of various
compounds. However, 9-nitroanthracene is noted in the literature to be a highly effective matrix
for use in the MALDI ionization process; for the analysis of fullerene compounds such as PCBM
(8,9,10). The matrices and analyte were made in toluene and chlorobenzene at the following
molar matrix to analyte ratios: 5000:1, 2000:1, 1000:1, 750:1, 500:1, and 250:1. Dithranol and 9nitroanthracene were compared and contrasted amongst the varying molar matrix to analyte
ratios and against the application process of the sample to the target plate. Two application
processes were used, the dry droplet technique and the aerospray technique. In addition, LDI
spectra of PCBM in toluene and chlorobenzene were also acquired and compared against spectra
acquired by MALDI. The relative laser power was varied and the influence of the laser was
optimized for obtaining the best possible spectra.

Experimental
Materials:
9.4T Bruker Ultraflex FTMS
Nd:YAG Laser (355nm)
9-nitroanthracene, 95%, Aldrich, CAS# 602-60-8
1,8,9-trihydroxyantracene (dithranol), 97%, Alfa Aesar, CAS# 1143-38-0
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-cyano-4-hydroxycinnamic acid (CHCA), CAS# 28166-41-8
Standard Peptide Mix II: Angio 21 (MW: 1045.533900m/z), Angio 1 (MW: 1296.684400m/z,
SubsP (MW: 1347.736100m/z)
Sample Preparation Method:
The matrices 9-nitroanthracene (5*10-02M) and dithranol (5*10-02M) were used in
combination with the solvents chlorobenzene and toluene to make several different molar matrix
to analyte combinations for PCBM (2*10-04M) analysis. The following molar matrix to analyte
ratios of 5000:1, 2000:1, 1000:1, 750:1, 500:1, and 250:1 were prepared in toluene for both
matrices. The molar matrix to analyte ratios of 5000:1, 2000:1, 1000:1, and 500:1 were prepared
in chlorobenzene for both matrices. The prepared samples were all applied to a stainless steel
target plate by the dry droplet technique for FTMS analysis. However, only the 1000:1, 750:1,
500:1, and 250:1 molar matrix to analyte ratios composed in toluene for both matrices was
applied using the aerospray technique.
The dry droplet technique consisted of using a small aliquot of each sample and applying
it to the target plate where it was left out to evaporate—each sample was plated with
approximately three 1μl aliquots of sample. The aerospray technique consisted of aerosol
particles being spewed from the end of a needle after being conveyed from the sample container
by a controlled flow of nitrogen—each application consisting approximately of 50-100μl of
sample.
Instrumentation of FTMS:
The samples were analyzed using a 9.4T Bruker Ultraflex FTMS with external ionization
source, and a stainless steel target plate while varying the Nd:YAG (355nm) laser power. The
laser power was varied relative to its maximum potential at the following percentages, 30, 40,
50, 65, 80, and 100. At each relative laser power three or more mass spectra were obtained and
each spectrum was generated from 35 scans each consisting of 30 laser shots. The instrument
was calibrated externally using a standard II peptide mix, and referenced against the peptides
Angio 1, Angio 21, and SubsP.

Results & Discussion
Preliminary findings suggest toluene and dithranol as optimal matrix and solvent for MALDI:
The preliminary findings consisting of the molar matrix to analyte ratios of 5000:1,
2000:1, 1000:1, and 500:1 composed in all possible forms of matrix and solvent; found that
toluene was a more preferred solvent than chlorobenzene as it resulted in an order of magnitude
higher for the PCBM signal intensity. Of the matrices dithranol and 9-nitroanthracene, the
preliminary results showed that dithranol gave an order of magnitude higher than 9nitroanthracne for PCBM signal intensity. Also it was noted that 9-nitroanthracene gave no
signal intensity for the analyte PCBM at a molar matrix to analyte ratio of 5000:1 for both
solvents, and it failed to give a signal at 2000:1 when the solvent chlorobenzene was used.
Spectral Interpretation as they pertain to the matrices and solvents for optimization in MALDI:
Therefore, further analysis of PCBM was conducted using only toluene as the solvent
with dithranol and 9-nitroanthracene as the matrices. Spectra where obtained at molar matrix to
analyte ratios of: 5000:1, 2000:1, 1000:1, 750:1, 500:1, and 250:1. The aerospray technique was
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found to be superior to the dry droplet technique in all the obtained spectra. The use of dithranol
at a molar matrix to analyte ratio of 250:1 resulted in the best spectra (figure 1 & figure 2) when
it was deposited in by the aerospray technique—see figure 3 for possible reactions that lead to
the observed species in figure 2. The best spectra (figure 4) of the 9-nitroanthracene matrix was
significantly improved when it was applied using the aerospray technique, however, the signal
intensity and signal to noise ratio were an order of magnitude less than those obtained by
dithranol—by the same process. The resolution obtained for dithranol and 9-nitroanthracene was
very similar in nature, and allowed for isotope peaks to be clearly resolved as a result of the high
resolving power of FTMS. The best spectra noted above were found to occur at a relative laser
power of 50%.
Influence of Relative laser power on varying molar matrix to analyte ratios:
The relative laser power at various molar matrix to analyte ratios was used to generate
bar graphs of the absolute signal intensity of PCBM and the associated signal to noise—which
are displayed in figure 5 & 6, respectfully. The higher the relative laser power the more
fragmentation that resulted and the relative laser power that was set too low resulted in no
obtainable spectra. The relative laser power was found to peak at around 40-50% for both
matrices, but 50% gave the best spectra.
Formation of oxidized and hydrated species of PCBM:
The spectra of PCBM obtained using MALDI as the ionization process shows several
oxidation and hydration species present. The spectrum shown in figure 3 shows the location of
the hydration and oxidative species of PCBM—which can be clearly seen up to the addition of
the fifth oxygen and hydrogen. The best spectra (figure 7) obtained using LDI as the ionization
process shows the oxidation and hydration of PCBM, but to a much lessened extent. However,
the peak at 719.9m/z, identified as the fullerene bulky ball [C60]+•, has varying signal intensities
between both matrices and ionization processes as shown in figures 1, 2, 4, and figure 7.
LDI and MALDI in relation to Fragmentation and absolute PCBM signal intensity:
In LDI the bulky ball peak dwarfs the PCBM peak which is the opposite in comparison to
the MALDI ionization process. However, this is to be expected due to the radiation energy from
the laser, which is transferred solely to the analyte in LDI. As a result of the analyte receiving all
the energy from the laser it fragments into its next smallest segments, a bulky ball and a methyl
ester side group.
The MALDI ionization process also differs in this peak between matrices, dithranol has
a higher bulky ball peak than does 9-nitroanthracene, while the same is true for the
corresponding PCBM peak intensities. The signal intensities are related to the amount of ions
present in the detector, which explains why dithranol has higher peak at 719.9m/z. Dithranol is
causing more ionization and therefore more ions than 9-nitroanthraene, and this large increase in
ions leads to more fragmentation, and therefore, a higher peak intensity for dithranol at
719.9m/z. However, the cause for this difference is still not completely answered, figure 3 shows
a spectrum of 9-nitroanthracene, and it can be seen that the amount of fragmentation is much
more expansive with several smaller ion fragment peaks evident than that seen using dithranol as
a matrix. Therefore, 9-notranthracene suffers from higher fragmentation than does dithranol.
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Figure 1: Spectrum of PCBM (matrix-dithranol, toluene, 250:1, aerospray technique).

Resolution:132,000
S/N: 1446
Good resolution
Good signal to noise
Good peak intensity
Aerospray technique yields best results
Optimal matrix:analyte ratio is 250:1 for dithranol
The least amount of fragmentation and the preferred
matrix of choice for PCBM analysis

[C39H72]

[PCBM]

[C60]
[C70H11]
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Figure 2: Spectrum of PCBM, expanded section of the above spectrum.

[PCBM]

[PCBM]

[PCBM+H]

[PCBM+2H]
[PCBM+3H]

[PCBM‐H]

[PCBM+4H]

[PCBM+O+H]
[PCBM+2O+H]
[PCBM+3O+H]
[PCBM+O]+

[PCBM+4O+H]
[PCBM+2O]

[PCBM+5O+H]

[PCBM+4O]

[PCBM+3O]

[PCBM+5O]

Figure 3: Possible reactions that lead to oxidized and hydrated PCBM species in the above mass
spectrum.

[PCBM+nO]
+nO
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+nO

‐H

+nO
+nH

[PCBM]
+n13C

[PCBM+nH+nO]

[PCBM+nH]

[PCBM+n13C]

[PCBM‐H+nO]
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Figure 4: Spectrum of PCBM (matrix-9-nitroanthracene, toluene, 750:1, aerospray technique).
Resolution: 136,000
S/N: 206

[PCBM]

Good resolution
Poor signal to noise
Poor peak intensity
Aerospray technique yields best results
Optimal matrix:analyte ratio is 750:1 for 9‐
nitroanthracene
More fragmentation than dithranol and not a
preferred matrix for PCBM analysis.

[C39H72]

[C60]

[C70H11]

Figure 5: Comparison of absolute peak intensity across several molar matrix to analyte ratios,
composed in toluene, and deposited by various techniques.
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Figure 6: Comparison of signal to noise ratios for various molar matrix to analyte ratios,
composed in toluene, and deposited by various techniques.

Figure 7: LDI spectrum of PCBM in toluene @ a relative laser power of 50%.
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Conclusion
In conclusion reference spectra were obtained, and a peak at 910.1m/z which corresponds
to PCBM was observed. Various fragmentation patterns resulted in correspondence to the
intensity of the laser, the matrix/solvent, the molar matrix to analyte ratio, and the technique
(aerospray or dry droplet) used in the application of the prepared sample. Due to the known
problematic reproducibility of MALDI, the error associated with our experiment in measuring
signal intensity was significant, but allowed for a more directional analysis of the accurate FTMS
reference spectra.

Future Considerations
Future considerations should include NMR analysis of the PCBM sample for prior
oxidation and hydration reactions. Also the maximum potential power of the Nd:YAG laser
should be measured to bring significant meaning to the obtained laser percentages gathered to
date. Another consideration for the future is the use of 2-[(2E)-3-(4-tert-butylphenyl)-2methylprop-2-enylidene]malononitrile (DCTB) as a matrix for PCBM to be studied via MALDIFTMS (10,11).
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Exploring New Reactivity of 2H-Azirines in Organocatalysis
and Metal Catalysis
Jean-Marie Charles, Cameron University
Lawton, Oklahoma

Abstract
The chemistry of 2H-azirines is dominated by ring strain and therefore highly favors the
processes in which the strain is relieved1. Thus, this study focuses on exploring
organocatalyzed opening of 2H-azirines to synthesize pyrrolidines with up to four
continuous stereocenters. It is proposed that nucleophilic attack of 2H-azirines on the
acrolein will be activated by a secondary amine and subsequent ring-opening of 2Hazirines by the resulting enamine would provide a highly substituted pyrrolidine after
reduction.
A new FeCl2 catalyzed method for the synthesis of indoles from 2H-azirines has recently
been developed in Zheng’s lab. This study also focuses on increasing the efficiency of this
method by synthesizing the indoles directly from the pentafluorobenzoates of oximes hence
bypassing 2H-azirines as the intermediate.

Introduction
Carbon-nitrogen(C-N) bond formation has been shown to play an important role in drug
discovery. A recent survey of GMP (Good Manufacturing Practice) reactions ran in Pfizer’s pilot
plants showed that it accounted for 15% of the reactions during the period between 1985 and
20022. It is steadily rising due to the increasing use of nitrogen-containing compounds as
pharmaceuticals and biological probes. Though there are various methods available for C-N
bond formation, many of them depend on functional group interconversion and form only one
bond3 and are not very efficient or environmentally sustainable. For this reason, the focus of my
REU studies at the University of Arkansas was to explore 2H-azirine chemistry in the synthesis
of pyrrolidines and indoles. This is a part of the Zheng group’s long term goal to create
economical, efficient, environmentally sustainable methods centered on C-H functionalization
and cascade reactions.
2H-azirines are the smallest unsaturated nitrogen-containing heterocycles. Two isomers
of azirines are known to exist: 1H-azirines containing a carbon-carbon double bond, and 2Hazirines having a carbon-nitrogen double bond in the three-membered ring. 1H-azirines, which
are anti-aromatic, are much less stable than 2H-azirines and tautomerize into 2H-azirines. 2Hazirines possess a highly reactive nature that is influenced by their ring strain, making them
useful precursors to synthesize more elaborate heterocycles4. Although this class of compounds
has been used as building blocks to synthesize other heterocycles, they have been seldom studied
in organocatalysis and hence influenced our interest in doing so.
Interests in synthesizing indole derivatives have been flared since they have been shown
to be useful in pharmaceutical compounds and bioactive natural products5. Recently, a new
catalytic method for the synthesis of indoles using substantially cheaper and environmentally
responsible iron salts was developed in Zheng’s lab. Although there are many procedures
available for the preparation of indoles, it is still a challenge to synthesize indoles bearing
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various substituents from readily available starting materials6. Thus, the aim was to increase the
efficiency of this new method by synthesizing indoles directly from the pentafluorobenzoates of
oximes hence bypassing 2H-azirines as the intermediate.

Synthesis of 2H-Azirines

Three 2H-azirines were used in the study. Azirines 7 and 8 were synthesized using
sequence I and azirine 9 was synthesized via sequence II. Sequence I was developed by
Douglass F. Taber. In this sequence, ketone 1 was converted to oxime 2, which was subsequently
converted to 2H-azirine 4 via mesylate intermediate 3.
The conversion of ketone 1 to oxime 2 was accomplished by adding hydroxylamine
hydrochloride and sodium acetate to ketone 1 in methanol/water (20:1), providing 2 as a racemic
mixture of E and Z isomers in 86% combined yield. It was assumed that only one of the isomers
would form 2H-azirine 4 if the vinyl nitrene intermediate was not involved in the ring formation.
Therefore, the two isomers were separated using silica gel chromatography and parallel reactions
were set up to test this assumption. Indeed, it was observed that after the addition of
triethylamine and methanesulfonyl chloride followed by 1, 8-Diazabicyclo[5.4.0]undec-7-ene
(DBU) only the major isomer, presumably the E isomer, was converted to azirine in 40% yield.
Sequence I

R2

R2

R1
R

R1

3

R3

O
1
NH 2OH .HCl, NaOAc
MeOH:H 2O (20:1)
R
3

N
2

4
DBU

2

R1
R

N

OH

R2
Et3N, THF
MsCl

R1
R3

N
3

OMs

Taber D.F.; Tian, W. J . Am. Chem. Soc. 2006, 128, 1058-1059.

Scheme 1. Sequence for Synthesis of 2H-Azirines 7 and 8
The synthesis of 2H-azirine 9 was accomplished using sequence II developed by Padwa
and Carlsen. In this sequence, treatment of oxime 1 with dimethylhydrazine in the presence of
sodium acetate and acetic acid afforded dimethylhydrazone 5, which was then converted to
20

quaternary ammonium salt 6 via a reaction with methyl iodide and then finally cyclized into
azirine 4 by the treatment of sodium hydride.
Sequence II

R2

R2

R1

R1
R3

R3

N

O
1

4
NH2NMe2
NaOAc
AcOH

NaH
R2

R2
R1
R3

N
5

R1

MeI

R3

NMe2

N
6

NMe 3

I
Padwa, A.; Carlsen, P.H.J. J . Org. Chem. 1978, 43, 2029-2037.

Scheme 2. Sequence for Synthesis of 2H-Azirine 9

Results and Discussion
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Scheme 3. Proposed Synthetic Route for Pyrrolidine Derivative
Scheme 3 shows our proposed synthesis of a pyrrolidine derivative starting from 2Hazirine 7. In this scheme, it was proposed that the secondary amine would undergo 1, 2-addition
to acrolein converting the carbonyl group to an iminium ion and thereby making the C4 carbon
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more electrophilic. Since the 2H-azirine nitrogen atom is reasonably nucleophilic, it was
expected that it would attack the C4 carbon of the iminium ion to generate an enamine. Then
subsequent ring-opening of 2H-azirines by the resulting enamine would form an intermediate
that would convert to an aldehyde by exposure to water, the byproduct from the formation of the
iminium ion, and regenerate the secondary amine thus completing the catalytic cycle. Finally
after reduction, the highly substituted pyrrolidine would be obtained.
Azirine 7 and acrolein were combined in THF with two different amines separately: first
pyrrolidine, then L-proline. However, in each experiment no reactions were observed, with 2Hazirine 7 being completely recovered.

Then separately, in the presence of L-proline, 2H-azirine 9 was treated with acrolein,
methyl vinyl ketone and cyclopentenone respectively. However, no reactions were observed in
these experiments either. It is proposed that the nitrogen atom in these 2H-azirines were not as
nucleophilic as had been anticipated and thus the reactions did not follow the synthetic scheme.
OH
1

R
Me

N
H
O
(20 mol%)

O

+

R2

N

No Reactions

CHCl3, 50°C, 12h

9

O
R1

O

:
R2

H

O

H
H ,

O
Me ,

The proposed synthetic scheme for indole derivative 13 is depicted in scheme 4. It was
assumed that treatment of pentafluorobenzoate 12 with a metal catalyst in THF would provide
the indole derivative via an imine radical, which would undergo cyclization onto the benzene
ring.
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Scheme 4. Proposed Synthetic Route for Indole Derivative
As shown in Table 1, several reaction conditions were set up using pentafluorobenzoate
12 with some transition metal catalysts in THF. Indole 13 was not isolated in any of the
reactions. Instead there were several byproducts observed, one of which was identified as 4bromophenylacetone 14. We thought that we were not able to obtain the desired indole
derivative because the imine radical did not cyclize onto the benzene ring as expected.
Table 1. Catalyst Screening
Me
O
N

Br

F
F

O

THF, 70°C, 12h

12
F

Me

catalyst
Br
13

N
H

F
F

entry
1
2
3
4
5
6

catalyst (mol %)

13, yield (%)

CuCl (50)
CuCl2 (50)
CuTC (50)
[CF3SO3Cu]2·C6H5CH3 (10)
FeCl2 (50)
FeCl3 (50)

0a
0
0
0
0
0a
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Conclusion
In conclusion, in this study we have examined the reactivity of 2H-azirines with enals
and ketones. We observed that 2H-azirines were completely recovered in the experiments and
the desired pyrrolidine derivative was not formed. We were not able to obtain the indoles directly
from the pentafluorobenzoates of oximes either. We did, however, observe several byproducts in
the screening experiments, one of which was identified as ketone 14.
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Computer Modeling of the Thermal Rearrangement of
2-aryl-2H-azirines to Indoles
Vernon D. Crowell Jr., Lyon College
Batesville, AR

Introduction
Indoles are aromatic bicyclic nitrogenous compounds, and consist of a benzene ring fused
to a five-membered pyrrole ring.1 These compounds see wide use in the pharmaceutical
industry and are commonly found in nature. This has inspired synthetic chemists to devise
practical methods to produce indoles, methods that should tolerate a wide range of functional
groups.2 Current experimental work by Zheng et. al seeks to investigate a process that has been
known since the 1970s: the thermal rearrangement of 2-aryl-2H-azirines to indoles. This method
allows for the simultaneous introduction of substituents onto carbons 2 and 3 of the indole
heterocycle. Also, 2H-azirines are easily prepared from common ketone precursors.3 Prior
investigations of this reaction were catalyzed by either Pd(PhCN)2Cl2 or Rh2[OC(O)CF3]4.
These catalysts are expensive, so Zheng et. al sought cheaper alternative catalysts. In an attempt
to optimize catalytic conditions, a number of Fe(II), Fe(III), Cu(I), and Cu(II) compounds were
allowed the opportunity to react with the 2H-azirine in a variety of solvents. It was determined
that FeCl2 in THF provided the highest yield of the indole product. In fact, THF was the only
solvent that allowed the Fe(II) rearrangement to go to completion, suggesting the formation of a
iron(II)-THF complex. This information and the previous discovery that 2H-azirines rearrange
to indoles via vinyl nitrene intermediates led to the proposal of a catalytic cycle involving
Fe(II).4
R'

R'
R"

X
2

N
H

Fe 2+

R'
X

R"

N
1

X

R'

R"
N
H [Fe] 5

X

N
[Fe]

R"
3

R'
R"
X

N 4
[Fe]
Figure1. The catalytic cycle proposed by Zheng et al.

In the above cycle, R can be phenyl, alkyl, or a hydrogen. R′ can only be phenyl or methyl. If
R′ is a hydrogen, the reaction doesn’t proceed within 24 hours.
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Computational Details
The catalytic cycle proposed by Zheng et al. was modeled using density functional
theory(DFT) with the PQS program package. Calculations were peformed using the B3LYP
hybrid functional with the m6-31g-d basis set. DFT is able to provide quite accurate results for
many systems at a lower computational cost than post-Hartree-Fock methodologies. In the
present context, it is important that DFT works well for transition metals where a number of
other methods have difficulties.5 There are many variants of DFT, depending on the choices of
the exchange-correlation functional that is used to mimic the effect of electron correlation.
B3LYP is perhaps the most widely used exchange correlation functional, and has been
thoroughly tested for transition metal compounds. Another important question is the choice of
the atomic basis set used to describe the molecular orbitals. This should be large enough to
allow accurate predictions but not so large that the calculations become too expensive. The 631g(d) basis is generally accepted as a reasonable compromise. However, for late transition
metals, it has a deficiency that has been corrected in the m6-31g(d) basis.
Full geometry optimizations were performed on the initial reactants, the product indole,
and the intermediates. The use of optimized scans allowed the discovery of approximate
transition state geometry. These approximate geometries were then used to perform transition
state optimizations.
The initial catalyst was assumed to be the high spin tetra-coordinated Fe(THF)2Cl2.
Since it was found that FeCl2 only catalyzed the rearrangement in THF solvent, it is likely that a
complex forms between the iron(II) chloride and the THF. Due to the low dielectric constant of
the THF solvent, it is unlikely that a chloride ligand is displaced by either THF or the 2H-azirine.
Also, a complex with more than two THF ligands is likely less stable due to steric effects.
Because both the chloride and the THF ligands are weak-field ligands, the iron(II) complex
should be high-spin. It has been noted6 that four coordinate complexes with large ligands and
small metal ions prefer a tetrahedral structure. With a d6 ion in a high-spin tetrahedral ligand
field, the complex should be most stable in the quintet state.
Initial calculations were for species with methyl groups attached to C2 and C3 of the
azirine ring. Some calculations were later performed with hydrogen replacing the methyl group
as the substituent on C2. In the first step of the reaction, the 2H-azirine displaces a THF from
the Fe(THF)2Cl2 complex. After obtaining the optimized geometry of the azirine iron complex,
the unusually long C-N single bond (1.546 Å) was scanned in an attempt to find an approximate
transition state in the vinyl nitrene formation step. However, when the C-N bond length
approached 2.0 Å, a region of triplet instability resulted in the inability of the SCF to converge.
Instead of starting the scan with the iron(II)-azirine complex, we reversed the direction of the
scan, and scanned the C-N distance from 2.4 Å (a little longer than the C-N distance in the
optimized nitrene) to 1.5 Å, a little shorter than the C-N distance in the azirine ring. Initially, the
distance was incremented by .05 Å, but this led to an inaccurate approximation of the transition
state, due to not having a well defined local maximum along the reaction path. By running
smaller scans in the area of the maximum, a better approximation was obtained. This
approximate transition state was then optimized. After optimization, a frequency calculation was
performed to verify that the optimized structure was a true transition state. Transition states must
have only one imaginary frequency, since a transition state is only a maximum along the reaction
path and a minimum along all other paths. The frequency is imaginary at a maximum due to the
negative force constant. The vibrational frequency can be expressed classically as
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f=
where k is the force constant and μ is the reduced mass of the system. Since at a maximum the
energy of the system can only go down along the reaction path, the force constant corresponding
to the reaction coordinate is negative, which formally results in an imaginary frequency. Even
after affirming that the geometry is a transition state, it is necessary to verify that it is the correct
transition state. In a large system such as the azirine complex, there are many possibilities for
conformational changes, which correspond formally to transition states but are of little interest.
In order to verify that the transition state corresponded to the breaking of the C-N bond, vectors
of the imaginary frequency were viewed. The vectors with the highest magnitude corresponded
to the breaking of the C-N bond.
Another optimized scan was performed to locate the approximate transition state in the
formation of the indole tautomer. The coordinate scanned this time was the distance between the
nitrogen and the benzene carbon ortho to the initial azirine ring. Scanning from 2.9 to 1.35 Å
with steps of .05 Å, an approximate transition state geometry was found. The transition state
was verified with a frequencies calculation and by checking the vectors of the imaginary
frequency.
The next reaction step involved the migration of the hydrogen on the bridgehead carbon
bound to the nitrogen to the nitrogen. This migration also led to the aromatization of the system
and significantly lengthened the N-Fe bond. A scan was performed that incremented the H-N
distance by .025 Å from 2.10 to .975 Å. The approximate transition state geometry was
optimized and verified. After the H-migration the iron(II) complex breaks off, reforming the
initial catalyst.

Results/Discussion
After obtaining all the transition state geometries along the catalytic cycle, the barrier
heights of each reaction step were calculated.
Reaction Step
IM1-IM2
IM2-IM3
IM3-IM4

Barrier Height (kcal/mol)
8.06
15.27
24.07
Table 1 : Barrier heights for various steps in the catalytic cycle.
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Compounds
IM1 + THF
TS1 + THF
IM2 + THF
TS2 + THF
IM3 + THF
TS3 + THF
IM4 +THF
PDT +C

Energy(kcal/mol) Relative to R + C
1.48
9.54
2.60
17.87
-14.66
9.41
-36.19
-44.96
Table 2: Energies relative to the reactant are shown.

R

IM4

IM1

PDT

IM2

IM3

C

The highest barrier between intermediates is TS3 which is 24 kcal/mol above IM3. This
would imply that the hydrogen migration step is the rate determining step. However, this would
be the case only if IM3 reaches thermal equilibrium with the surroundings before it reacts
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further, which is not likely. At the moment of its formation, IM3 is hot (it is more than 30
kcal/mol below TS2), and this energy is deposited in the immediate vicinity of the migrating
hydrogen atom, giving it ample energy to overcome the TS3 barrier. Moreover, hydrogen
migration is known to occur through tunneling, meaning that the full activation energy wouldn’t
be needed for the reaction to proceed. It is much more likely that the formation of the indole
tautomer in the preceding reaction step determines the reaction rate. This transition state (TS2) is
calculated to be significantly higher relative to the reactants than TS3. It is interesting to note
that for the H substituted azirine, the barrier to the formation of the indole tautomer is 18.81
kcal/mol, which is 3.54 kcal/mol higher than the methyl substituted system. Using the Arrhenius
equation, the relative reaction rate of indole tautomer formation between the differently
substituted systems can be determined. The tautomer formation step is estimated to be 180 times
slower in the H substituted molecule than in the methyl substituted system. However, this
reasoning omits the role of the quasi-equilibrium between the reactants and IM2. In the hydrogen
form, IM2 is lower relative to the reactants than in the methyl form. In the quasi-equilibrium
picture, the relative reaction rates are determined by the energy of TS2 relative to the reactants.
The hydrogen form is still estimated to react more slowly than the methyl form but the ratio is
only about 1:6.

Conclusion
The proposed catalytic cycle of Zheng et al. seems to be plausible. The rearrangement
begins when the azirine displaces a THF from the iron(II) catalyst. The long C-N bond of the
azirine ring is broken to form a vinyl nitrene complex. Then, in the probable rate determining
step, an indole tautomer is formed after a barrier of around 15 kcal/mol is overcome. After the
formation of the tautomer, the hydrogen migrates and the iron(II) complex is expelled, forming
the indole product.

Future Plans
In the future, the geometries of important points of the reaction path will be reoptimized
using a larger basis set. Also, different exchange-correlation functional will be used.
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Progress toward Water Soluble Mono-Functionalized
Nano Particles for Biological Sensors
Anna Fielder, University of Arkansas
Fayetteville, Arkansas

Abstract
The specific aims of this project are to synthesize, characterize, and optimize appropriately
functionalized dendrons for ligation to nontoxic quantum dots (QD’s) in order to increase
water solubility via solid phase “click” chemistry. Once completed, addition of a single
protein, specifically Cdc42 - a member of the Ras proteins, will attach in one of four
locations: the C-terminal his6-tag, a free cysteine, a free lysine, or a p-AcPhe.

Introduction
Understanding science at the nano level has become increasingly important in today’s
world. The idea of the applications for tools at the atomic level has been around for many years,
as expressed by the Nobel physicist Richard Feynman.1 Thanks to current research, many
diagnostic applications as well as intracellular imaging applications for QD’s have been
determined, summarized in Figure 1. 2

Figure 1
In this project, two classes of newly developed doped quantum dots (d-dots) and NIRemitting core/shell/shell QD’s will be used. As opposed to QD’s previously studied, d-dots and
core/shell/shell QD’s do not contain the toxic compound cadmium, making them safer for
biological applications. D-dots have the advantages of large thermal stability and are zero selfquenching. Synthetic techniques of the Peng research group will be employed. 8-12 Currently,
literature exists that provides methods for preparing mono-functionalized Au nanocrystals.3-7
Some of these ideas will be carried over into the research of the mono-functionalized watersoluble d-dots as well.
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Once mono-functionalization and water solubility have been achieved, the aim is to
attach a single protein to the mono-functionalized location. Cdc42 will be used which a member
of the Ras (Ras Sarcoma) super family of GTP-binding signaling proteins. The Ras proteins
were among the ‘first’ human oncogenic proteins to be identified.13 30% of cancer’s have shown
to contain mutated expressions of the Ras proteins, therefore making it a great protein to attach
for bioimaging. The overall goal is summed up in Figure 2.
His tag

Cysteine

X

d-dot

p-AcPhe

O

Lysine

Figure 2
Scheme 1 represents the outline of the chemical target whose synthesis will be outlined in
Scheme’s 2 and 3. Due to insolubility of ligated nanoparticle, solid phase synthesis reactions with
click chemistry give rise to a water-soluble ligated nanoparticle.
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Results and Discussion
1. Ligand Synthesis
The overall scheme of the ligand synthesis is represented in Scheme 2. It proceeds in
good yields without need of extensive purification.
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Scheme 2

Triethylene glycol 3 was treated with NaOH and Propargyl bromide at 40’C for 2 hours to
give the Polyethylene Gylcol (PEG) alkynl alcohol 4 in 80% yield. The remaining 20% was the
disubstituted dialkyne. To compound 4, was added an aqueous solution of 40% w/w NaOH, 10%
Tetrabutylammonium bromide (TBAB), and Epichlorohydrine 1, to give the alkynyl epoxide 5 in
>95% yield. To compound 5, was added a sodium methoxide solution prepared by adding Na
metal to MeOH to give the first generation (1G) alcohol 6 in 93% yield. A similar reaction was
done between epichlorohydrine and sodium methoxide solution in MeOH to give the dimethoxy
alcohol 2 in 60% yield after vacuum distillation. To the 1G was added compound 1, TBAB, and
40% aq. NaOH to give compound 7 in >95% yield. To compound 2 was added NaH under inert
N2 atmosphere to form the alkoxide followed by addition of 7 to give compound second
generation (2G) 8 in 77% yield after chromatography. It is important to note that there was no
purification required for the first series of reactions. The only byproduct, the dialkyne from the
first step, was an un-reactive intermediate that was carried through to compound 8 where it was
removed by column chromatography. Compound 8 was added to a solution of NaH in THF
under N2 followed by 1,6-Dibromohexane and stirred for 3 days to create the second generation
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alkyl bromide 9 in 89% yield. Finally, combined with 9 was a trityl (tripheynlmethane) protected
thiol, 18-crown-6, K2CO3, MeCN and DMF and left to stir for 20 hours at 85’C to obtain the
third generation (3G) protected thiol target ligand, compound 10, in a 75% yield after
purification.
2. Optimization of Water Solubility
Due to the insolubility of the nanoparticle after ligand exchange, something had to be
added to the ligand to increase solubility. Two separate methods to prepare the same
compound 13 were tried as shown in Scheme 3.
A
O

Cl

O

Cl

11

1. NaN3
TBAB
2. Na Metal
MeOH

49%
O

O

O

B

O

1. TsCL
DMAP, DCM
2. NaN3
Et3N
OH
Acetone:Water (4:1)

O

O

N3

13

82%

12

Scheme 3
In reaction A, compound 11, NaN3 and TBAB, followed by a secondary reaction of
Sodium metal and MeOH to give rise to compound 13. In order to optimize the reaction
conditions and minimize the diazide byproduct, parallel synthesis was performed with the
following ratios and results listed in Table 1.

Sample
1
2
3
4
5
6

Dichloro
4
3
2
1
1
1

NaN3
1
1
1
1
2
3

TBAI (g)
Dichloro
0.003
83%
0.003
78%
0.003
76%
0.003
40%
0.005
0%
0.0086
0%
Table 1

Mono-Azide
17%
22%
22%
49%
37%
0%

Di-Azide
0%
0%
2%
10%
62%
100%

Due to availability of starting materials, greater yield, and lack of bi product such as
the di-azide, reaction 2 proved to be more efficient in synthesizing the mono-azide compound
necessary to improve water-solubility. In reaction B, compound 12 was reacted with TsCl,
DMAP, DCM, and Et3N to give the desired compound 13 in an 82% yield.
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3. Ligand Exchange Reactions
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Conclusion
Scheme 3 reactions were successful in creating water-soluble nanoparticles after ligand
exchange reactions as proved by the following pictures. Figure 3 shows that nanoparticles are
insoluble after ligand exchange in water before the mono-azide 14 was added, and Figure 4
shows that after addition of 14 ligated nanoparticles are now soluble in water! Future work
includes, but is not limited to, attaching QD’s to solid support via ‘Click’ cycloaddition, adding
PEG-azide 14 to remaining alkynes, and finally cleaving from bead used and attaching to a
protein.
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Experimental Procedures
4

Synthesis of compound 4: NaOH (8.45 g, 0.211mol)
was added to a stirred solution of ethylene glycol (100
80%
mL, 0.74mol) and the solution was heated up to 100’C
until the NaOH was dissolved, then cooled down to room temperature. Propargylbromide (24
mL, 80% weight in toluene solution, 0.269mol) was added to the solution and warmed up to
45’C. After 1.5-3 hr the reaction mixture was diluted with brine and extracted over ether several
times. The ether layer was dried over MgSO4, filtered and concentrated. H NMR (Bruker, 300
MHz, CDCl3),  4.18 (d, 2H), 3.72-3.63 (m, 10H, CH2), 3.60-3.57 (m, 2H, CH2), 3.61 (s, 1H,
OH), 2.42 (t, 1H). 14,15
5
Synthesis of compound 5: To a stirred solution of
O
4 (41.29g, 0.219mol), TBAI (6.85 g, 10mol%,
O
O
O
O
0.019mol) in the 40%NaOH solution (360mL) was
added drop wise epichlorohydrin 1 (50mL,
>95%
0.637mol). The mixture was stirred at room
temperature for 20hr. The reaction mixture was diluted with saturated K2CO3. Compound 5 was
extracted with ether. The ether solution was dried over MgSO4, filtered and concentrated. 1H
NMR (Bruker, 300M Hz, CDCL3),  4.18 (d, 2H), 3.79 (dd, 1H, CH), 3.42 (dd, 1H, CH), 3.66 (m,
12H, 6CH2) 3.15 (m, 1H), 2.78 (dd, 1H), 2.59 (dd, 1H), 2.41 (t, 1H), 13C NMR (Bruker, 75MHz,
CDCl3)  79.58, 74.64, 71.86, 70.60, 70.46, 70.28, 70.19, 70.03, 68.98, 58.28, 50.66, 44.16. MS:
245.2 (M+H), 263.1 (M+H + H2).
O

HO

O

O

Synthesis of compound 6: Na metal (9.0 g,
0.391mol) was added to MeOH (200 mL,
O
O
O
O
2.87mol) and stirred until Na was dissolved. 5
HO
(48 g, 0.197mol) was added to the solution then
O
93%
refluxed overnight. The next day, solution was
neutralized to Ph 7 with 3 M HCl (100 mL) then 6 was extracted with ether and DCM. 1H NMR
(Bruker, 300M Hz, CDCL3),  4.20 (d, 2H), 3.95 (m, 1H), 4.19-3.41 (m, 16H, 8CH2) 3.37 (s, 3H,
CH3) 2.87 (d, 1H, OH), 2.42 (1, 1H), 13C NMR (Bruker, 75MHz, CDCl3)  79.29, 74.55, 73.54,
72.26, 70.26, 70.10, 70.06, 70.03, 69.90, 68.77, 68.59, 58.67, 57.87. MS: 277.2 (M+H), 299
(M+Na).
6

7

Synthesis of compound 7: To a stirred mixture
of 6 (50 g, 0.181mol) TBAI (5.8 g, 10mol%,
O
O
O
0.16mol), in 40% NaOH solution (450 mL) was
O
>95%
added drop wise epichlorohydrin 1 (45 mL,
0.574mol). The mixture was stirred at room temperature for overnight (20hrs). The reaction
mixture was diluted with saturated K2CO3 solution and 7 was extracted with ether. The ether layer
was dried over MgSO4, filtered and concentrated. 1H NMR (Bruker, 300M Hz, CDCL3),  4.20
(d, 2H) 3.89 (dd, 1H), 3.71-3.45 (m, 18H, 8 CH2) 3.36 (s, 3H, CH3) 3.16 (m, 1H), 2.78 (dd, 1H),
2.62 (dd, 1H), 2.42 (t, 1H).
O

O

O
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Synthesis of compound 2: To the sodium methoxide solution prepared from
absolute methanol (100mL, 1.43mol) and sodium (3 g, 0.130mol) was added
HO
epichlorohydrin 1 (4.61g, 0.50mol). The mixture was refluxed for 20 hr under
O
N2. After, solution was acidified with 3M HCl; the reaction mixture was
60% concentrated under reduced pressure. The insoluble material was filtered and
compound 2 was the product. 1H NMR (Bruker, 300M Hz, CDCL3),  3.5 (t, 1H, OH), 3.47-3.38
(m, 4H, 2CHs), 3.37 (s, 6H, 2 CH3). 16
2

O

8

Synthesis of compound 8: NaH (841 mg, 0.035mol) was
added to 2 (10 equivalents) and stirred until NaH was
O
HO
dissolved. Compound 7 (7.5 g, 0.233mol) was added to the
O
77%
O
solution and heated at 65’C overnight. After checking TLC,
O
the reaction mixture was quenched with small amount of
water and excess amount of 2 was distilled off. The residue was chromatographed on silica gel to
give 8 in 77% yield. 1H NMR (Bruker, 300M Hz, CDCL3),  4.20 (d, 2H), 3.95 (m, 1H), 3.713.43 (m, 26H, 8CH2), 3.35 (s, 9H, 3CH3), 2.43 (t, 1H). , 13C NMR (Bruker, 75MHz, CDCl3) 
79.59, 78.55, 78.46, 74.63, 72.75, 72.68, 72.60, 71.91, 71.87, 71.23, 71.14, 70.72, 70.50, 70.39,
70.29, 69.72, 69.66, 68.96, 59.10, 58.26. MS: 453.1 (M+H).
O

O

O

O

O

O

O

Synthesis of compound 9: NaH was added to a stirred
O
solution of 8 (1.5 g, 0.003mol) in THF (20mL,
O
Br
O
89%
0.250mol) and the solution was stirred until NaH (350
O
mg, 2.2 equivalents, 0.015mol) was dissolved. After
15 minutes, 1,6-dibromohexane was added to the solution and the reaction was stirred at room
temperature for 3 days. After checking TLC, solid was filtered off and the solution was
concentrated. The residue was purified on silica gel to give 9 (1.63 g, 0.003mol) of 89% yield. .
1
H NMR (Bruker, 300M Hz, CDCL3),1H NMR (Bruker, 300M Hz, CDCL3),  .4.15 (d, 2H),
3.64-3.3 (m, 31H, 8 CH2) 3.30 (s, 9H, 3 CH3), 2.4 (t, 1H). 1.80 (m, 2H), 1.51 (m, 2H), 1.34 (m,
4H), 13C NMR (Bruker, 75MHz, CDCl3)  79.61, 78.35, 78.23, 78.18, 77.65, 77.22, 76.80, 74.65,
72.58, 72.55, 72.51, 72.48, 70.97, 70.94, 70.78, 70.57, 70.54, 70.48, 70.35, 70.16, 70.11, 69.03.
MS: 617 (M+H).
9

O

O

O

O

10

Synthesis of compound 10, 3G Ligand: To
the protected thiol (0.673 g, 0.002mol) was
S C(Ph)
N
added 0.50 g (0.004mol) K2CO3 and 0.15g
O
O
H
O
O
O O O
O
(0.0006mol)18-crown-6. 2.0 g 9 (0.003mol) in
O O
75%
O
40 mL acetone was added to reaction mixture.
Solution was refluxed at 75’C over night (16 hours). The reaction mixture was then
concentrated, redissolved in DCM, filtered and concentrated in vacuuo. The resulting residue was
purified by flash chromatography with silica 1:99 MeOH:EtOAc to give 10 in 75% yield as a tan
oil.
O

O

O

O
O
O
O

O
O

O

O

O
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Synthesis of 14: CuSO4 (0.0086 g) and Sodium
Ascorbate (0.0137 g, 0.00007mol) were added to a
vial followed by 10 (0.25 g, 0.0002mol) and 13
(0.0653 g, 0.003mol). To this mixture was added
1:1 THF/H2O (8 mL). The vial was capped and
heated at 50’C for 3 days. After TLC check, 14
was diluted with 10 mL saturated NH4Cl then
extracted with EtOAc, dried over MgSO4, filtered,
and concentrated to give 0.2603 g of 14 of 79%
yield. This was used without further purification.

Synthesis of chloroazide: For reaction A, to a stirred solution
of 11 (11.52 g, 0.062mol) was added DMF (30 mL, 0.390mol)
49%
until dissolved. To the mixture was added NaN3 (1.0g,
0.015mol) and TBAB (0.51g, 0.002mol). Solution was purged
with N2 and stirred over night at 80’C. Mixture placed under vacuum and then extracted with
ether and dried over MgSO4 and condensed to give rise to 13 (5.75g, 0.026mol).
O

N3

13

Synthesis of monoazide: For reaction B, to a stirred solution of
12 (5.0 g, 0.030mol) was added DCM (50 mL, 0.780mol). To this
O
O
O
N3 was added Et N (7.7 g, 0.076mol) then DMAP (0.4 g, 0.003mol),
3
and finally TsCl (11.5 g, 0.061mol). The reaction mixture was
82%
capped and stirred over night. Next, the solution mixture was
washed with DCM and was dried over MgSO4, filtered and concentrated. After checking TLC,
residue was chromatographed on silica gel to give rise to 13 (8.70 g, 0.046mol) with yield of
82%.
General synthesis for ligand exchange: To the protected thiol was added trifluoroacetic acid
(TFA)1.5 mL per 100 mg ligand, and triethlsilane (TES) 0.1 mL per 100 mg ligand. After 30
min stirring, the reaqction mixture was concentrated and dried. To the residue was added 3 mL
of MeOH and basified to pH>10 with tetrabutylammoniumhydroxide. This was added to the
semipurified nanoparticles in 2:1 w/w and refluxed 16 hours. The resulting red solution was
centerfuged to remove insoluble particles and purified by dialysis (nominal 2000) in MeOH.
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Methods towards Thiazolium Salt Rearrangements
Rebecca Foos, John Brown University
Siloam Springs, Arkansas

Abstract
Much of research within organic chemistry surrounds the methods of pharmaceutical
development. The compound thiazole is considered to be a favored structure in many
drugs, and as such methods by which it may be used synthetically are of great interest. This
study develops the chemical rearrangement of an n-allyl substituted thiazole to a terminal
alkylene chain at the beta carbon. Although the study is ongoing, successful rearrangement
has been observed with yields up to 38%.
Figure 1. Full desired synthesis reaction scheme, begun with a thiazole and producing an Ireland-Claisen
type rearrangement.
S
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S
X
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N

N

NaH, TMG
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r.t., 20 hr.
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N

N

Introduction
Thiazole is known as a “privileged” structure in the chemi-pharmaceutical world due to
its heavy use in drug syntheses. Fig. 2 shows several such drugs. Of course any drug of like these
takes many synthetic steps to produce. For this reason, the synthetic rearrangement developed in
this study (Fig. 1) is of great practical value in the field of pharmaceutical development, as it
may be used in further synthetic studies for drug development.

40

Figure 2a-e. Pharmaceutical examples of the repeated occurrence of thiazole base structure in drugs.
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A close predecessor to the target rearrangement 1 is found in the Kurth reaction of the
1980s, which saw the same rearrangement with an oxygen replacing the sulfur.I
R
R

O

R

O

O
HO

H 3O

rearrangement
N

OH

N

R

+

R
NH2
R

Figure 3. The Kurth Reaction, a method for isolating enantiomeric carboxylic acids via diastereomeric
properties of the rearrangement product; scheme shown depicts only steps 3 and 4.

However, this reaction was not intended for pharmaceutical application, but instead served as a
method towards enantiomerically selective production of a carboxylic acid via separation of the
intermediate diastereomers. While stereochemistry could play a small role and has the potential
to be exploited within this synthesis, this falls beyond the scope of this preliminary study.

Experimental Procedures
The first step in the rearrangement synthesis is the formation of the base salt (see Fig. 4).
By heating the thiazole system to 120°C with an allylic electrophile for up to five hours, the salt
is formed with up to 86% effectiveness. We favored the use of allyl tosylate, as the resulting
anion has a low nucleophilicity and will not encourage side reaction. (Allyl tosylate is not
commercially available, but was easily be synthesized by sodium hydroxide activation of an allyl
alcohol in the presence of tosyl chloride at 0°C in ether.II) Purification of the allyl-thiazolium
tosylate salt via trituration in ether to remove excess allyl tosylate and dehydration under high
vacuum gave high purity as seen in NMR analysis.III
S

Figure 4. Reaction scheme showing
the formation of the base thiazole salt.
X=Br, OTS

S
X

X


N

N

Following the salt formation, activation by base at the beta carbon by sodium hydride
gives the ketene acetal intermediate, which upon heating spontaneously rearranges.
S

S

X
N

NaH, TMG
toluene
r.t., 20 hr.

S


N

N

Figure 5. Rearrangement scheme.
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This process, without the interference of an allyl group, has been previously developed in very
complex systems giving suitably stable rearrangement products; however, there is a known side
product which must be avoided.IV Fig. 6 shows the process known as dimerization, which gives
an observed side product within the intended synthesis, a dimer of the original salt.
Figure 6. When not isolated from each other, the unreacted salt and activated ketene-acetal will react to
form a dimer of the original salt.

S

X
X

N
S

N

N

N

S

S

The side reaction may be avoided via very high dilution of the reaction mixture, which
essentially serves to isolate the formed ketene acetal from the unreacted salt. This may be
achieved in two ways:
1) by adding the salt in solution very slowly by syringe pump to a hot reaction mixture,
which will presumably allow the ketene acetal to immediately rearrange upon formation,
with low enough concentration that it will not kinetically be able to react with any unreacted
salt
2) by using a solvent in which the salt is insoluble, thereby limiting the presence of salt with
ketene acetal in solution by the innate solubility of the salt.V This second process also allows
for complete reduction to the ketene acetal and subsequent heating to drive the rearrangement
in a two step process, giving a bit more control and observability.
Via the second method, the procedure for the total rearrangement becomes rather
straightforward. The salt is placed in toluene in a pressure tube to prevent the toluene from
boiling off during heating. Sodium hydride (1.5 eq.) and tetramethyl guanidine (TMG, 8 eq.), a
base facilitating the proton transfer, are added to the solution and the ketene acetal is formed at
room temperature over a period of 20 hours.
At twenty hours, the reaction is placed in an oil bath and heated to 170 C for 2 hours.
Purification via extraction in ether and column chromatography gives the final pure
rearrangement product, verified by Nuclear Magnetic Resonance (NMR) Spectroscopy (see Fig.
7).
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Results
1
2

3

1

8
4

7

6
5

7

6

8

4

3

5

2

Figure 7. NMR spectra of displayed product system; the numerical peak assignments match the assigned
protons, as determined by theoretical NMR shift and splitting prediction.

The clean spectra detailed above shows the purity of the rearrangement product at above
90%. This particular reaction gave a yield of 38%, which in the initial stages of development is
rather high. My 2-methylbenzothiazolium rearrangement 8 gave 70% yield with above 90%
purity, and more recent yields done by Silvana Dormi have given yields as high as 90% with
good purity.
S

N

Figure 8. 70% yield benzylated thiazole rearrangement system.
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Conclusion
While the progress within this study has been very exciting, work has yet to be done.
Since my project ended, we have been looking into a few things. The main barrier towards this
rearrangement appears to be the formation of the ketene-acetal, as rearrangement on heating by
simulated studies would appear completely favorable. Hindrances to this step which we have
examined are the high excess of TMG. As this was part of a procedure referenced when
developing the study, we began with the prescribed 8 equivalences. However, recent time trials
have shown that a lower amount, just two equivalences, gives a more stable and complete
conversion to the ketene-acetal. This mini-study also tested the effectiveness of letting the
conversion occur over 20 hours, which indeed proved the most complete method, although the
majority of the salt had reacted within the first hour.
Further study will include labeling of the terminal rearrangement carbon via a methyl
group or some such analogous inert functional group to check positively that the mechanism is
indeed a rearrangement and not simply a electrophile/nucleophile intramolecular reaction.
Following this confirmation, more complex systems will also be examined for the effective use
of this rearrangement.
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Fluid Motion with Magnetohydrodynamics
Amanda Hicks, John Brown University
Siloam Springs, Arkansas

Abstract
The fundamentals of redox magnetohydrodynamics in a magnetic field parallel with the
plane of the electrode array are investigated in a confined solution. A parallel magnetic
field was created from two small permanent magnets held a few centimeters apart, creating
a magnetic field between them parallel to the chip. Electroactive potassium ferri- and
ferrocyanide were reduced and oxidized at the electrodes in order to create ion flux. The
cross product of the parallel magnetic field and the ion flux produces the magnetohydrodynamic force, which makes the fluid flow across the electrodes rather than around them
as has been previously observed with a magnetic field perpendicular to the array. Observed
velocities changed depending on the depth of the cell, the height within the cell that the
velocity was measured at, and the current being used. The fluid moves in four horizontal
circulations, moving in opposite directions over the working and counter electrodes and
being pulled back around the sides of the electrode to replenish the flow.

Introduction
There are many applications in microfluidics for MHD. The ability to move fluid without
the use of moving parts and the ability to switch directions very quickly makes it attractive for
use as a pump, which could be used for PCR, integrated microfluidic/NMR systems, or other
devices. MHD would also be useful for mixing within a small, confined volume where
traditional methods cannot be used. This paper demonstrates a pattern of four adjacent
circulations in the same plane which would be particularly useful for this.
Magnetohydronamic, or MHD force (FB) is defined by the rule FB= j X B. The force is
created by cross product of the ion flux j and the magnetic field B. What this force affects is the
fluid containing the ions, and the fluid moves in the same direction as the force. The directions of
each can be worked out using the right-hand rule; by pointing the fingers of the right hand in the
direction of B, and curling them into j, the thumb will point in the direction of the force.
In addition, using a redox species, here potassium ferri and ferrocyanide, eliminates some
of the traditional problems with using MHD, keeping electrodes from being destroyed by
oxidation and preventing electrolysis of water, which forms bubbles that hinder flow.
Previous small volume, chip-based studies have been performed with the magnet below
the chip, creating a magnetic field perpendicular to the plane of the chip. The study describe
herein differs in that it uses a pair of magnets held on either side of the chip to create a magnetic
field parallel to the plane of the chip. This is at a right angle to a different part of the ion flux
than has been previously studied. Unlike where with the perpendicular field, the edge effects
were what was observed, the primary force in these studies will be caused by the ion flux going
vertically in and out of the electrodes, which will cause the fluid to move differently, going
across the electrode instead of around it in circles.
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Experimental Procedures
Chemicals and materials. All chemicals were reagent grade and used as received.
Solutions were prepared using bottled deionized water from Ricca Chemical Company.
Potassium ferricyanide was purchased from EM Science (Gibbstown, NJ), and potassium
ferrocyanide trihydrate was purchased from J. T. Baker (Phillipsburg, NJ). Potassium chloride
was bought from EMD (Gibbstown, NJ). Polystyrene latex microspheres (10 µm diameter, 2.5
wt% dispersion in water) were acquired from Alfa Aesar (Ward Hill, MA). Sylgard 184 silicone
elastomer base and curing agent, used to make the polydimethysiloxane (PDMS) gaskets, were
obtained from Dow Corning Corporation (Midland, MI). Precleaned microscope slides (3 in. by
1 in. by 1.2 mm) were bought from VWR. Metal deposition on the chips was carried out using a
chromium-plated tungsten rod (Kurt J. Lesker Co., Clairton, PA), and fragments cut from a gold
coin (Canadian Maple Leaf, 99.99%) placed in a molybedenum boat (Kurt J. Lesker Co.,
Pittsburgh, PA) for evaporation, and all chips were based on silicon wafers (125-mm diameter,
600-650 thickness, and (100) orientation) with 2-µm, thermally-grown SiO2, purchased from
Silicon Quest international. Benzocyclobutene, BCB, (Cyclotene 4024-40) was acquired from
Dow Chemical Company. Electrical connection of the potentiostat to the contact pads on the
chip used an edge connector from Sullins Electronics Corp. (San Marcos, CA).
Reference
Chip design. Gold electrodes
Counte
were patterned onto silicon wafers and
Opening of
diced. Fabrication was performed by
PDMS Gasket
others in our laboratory and will be
Workin
describe in a susequent paper. The
general procedure for fabrication of a
Figure 1: photograph of the chip used.
different chip design can be found in Ref
[1]. Each chip is 1.2 cm long and 5 cm wide, and has nine individually-adressable large
electrodes. All electrodes are 2 mm long, and 3200, 2000, 800, 200, or 25 µm wide, with gaps of
1 mm between all except between the 3200 µm and 2000 µm electrodes. The chip is symmetrical
around the 25 µm electrode. In the magnetic field, the field is parallel to the 2000 µm side of the
electrodes.
In general, the 800 µm electrode closest to the leads was used as the working electrode,
with the 2000 µm electrode 1000 µm away used as the counter, and the 200 µm electrode located
1000 µm away on the other side was used as the reference. See Figure 1.
Magnetic Field. The parallel magnetic field setup consisted of two 0.5 T NdFeB sintered
permanent magnets (Amazing Magnets, Irving, CA) measuring 1 inch across and 0.25 inches
thick placed 2.3 centimeters apart, creating a field of 0.27 T at the center. The magnets were held
apart at that distance by a low carbon steel u-bar measuring 10 cm on each side and 2.5 cm thick,
with a cutout 7.5 cm long and 3.5 cm wide. The magnetic field was measured with a DC
magnetometer (Gauss) from AlfaLab Inc.
Because of the relatively small size of the magnets in relation to the chip, the magnetic
field was not even across the chip. The working electrode was always placed in the same spot in
the very center of the magnetic field in order to ensure that the force would be consistent so the
measured velocities would not change.
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Experimental setup. A PDMS film with a rectangular opening measuring 2.8 by 0.7 cm
cut into it was placed on the chip, with the opening exposing all electrodes over the entire chip.
This gap was then filled with the solution that contained the redox species, the electrolyte, and
the microbeads. A piece of a glass microscope slide was then placed on top as a lid. This created
a closed electrochemical cell, with the thickness of the PDMS defining the depth of the cell.
Four PDMS gaskets were used of thicknesses 620 µm, 940 µm, 1250 µm, and 2500 µm.
Because of the density mismatch between the solution and the beads, the beads tended to
sink or rise in the cell, so every experiment required a fresh solution. Replacing the solution also
involved washing the chip, the PDMS film, and the glass slide with deionized water, then drying
the chip with either N2 gas or argon purchased from Airgas (Danbury, CT) to blow the liquid off
of it. The PDMS and glass slide were dried with kimwipes purchased from Kimberly-Clark
Global Sales, Inc (Roswell, GA). Occasionally the chip was also rinsed with ethanol from
Pharmco-Aaper (Brookfield, CT) in order to prevent electrode fouling.
Movement of the microbeads was observed with a Leica DM 2500M microscope
outfitted with a Mitutoyo M Plan Apo 10 objective. The movies were recorded using a Sony
Handycam HDR-XR500 digital camera (30 frames per second, 1920 x 1080 pixels per frame).
Bead velocities given herein are the average velocity calculated from several, generally
four, microbeads. These velocities were determined by how far a bead traveled across the
electrode, using the width of the electrode as the scale, over a period of 10 s, determined by the
number of video frames that had passed. A frame was captured once every thirty frames, or once
per second, and the velocity measurements were calculated from these. All measurements were
taken 5 s after the current was first applied to ensure uniformity of the data. No movement was
observed in experiments without a current or a magnet present that could not be attributed to
density gradients.

Figure 2: Photograph of setup showing magnets,
chip, and PDMS gasket on microscope stage.
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Electrochemical Control. A CHI 760B potentiostat (CH Instruments, Austin, TX) was used for
chronopotentiometry and chronoamperometry in three-electrode configuration. For most
experiments, the working electrode was 800 µm wide by 2000 µm long, and it was 1000 µm
away from the counter electrode, which was 2000 by 2000 µm. The reference remained on the
other side of the working electrode from the counter, again 1000 µm away, and was 200 µm
wide by 2000 µm long. All solutions were 0.07 M K3Fe(CN)6, 0.07M K4Fe(CN)6, and 0.1 M
KCl unless otherwise specified, with either a 25X or 50X dilution of microbeads added while the
solution was being made as to not change the dilution of the other species.
A cathodic current of 30 µA was used for all experiments unless otherwise specified.
This current was chosen for the experiments because it is below the diffusion limited current, and
thus will not damage the electrodes or cause electrolysis of water, which would cause bubbles
that would hinder flow, but high enough to see a substantial amount of bead movement.

Results and Discussion
Characterization of the electrodes. In order to assure that all electrodes were working,
electrodes were initially characterized using Cyclic Voltammetry (CV) before being used. Figure
4 shows examples of CV responses for the 3 electrodes used in these studies. The peak current
for a range of 0.5 v to -0.5 v in .07M ferri/ferrocyanide is 270 µA at the 800 µm working
electrode. The calculated value for this current using ip = (2.69 X 105)n3/2ADo1/2Co*ro is 525 µA.
The reason for this inconsistency is unknown, but has been observed consistently over several
chips and electrode sizes.
Chronoamperometry was used to determine the safe
current limit for the electrodes. The 800 µm working
electrode gave a current of 38.4 µA over 40 s, which is
how the current most often used at 30 µA was obtained.

Figure 4: Cyclic Voltammogram
of the 800 µm electrode.
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Does the bead velocity change over time?

Figure 5: Graph of bead velocity over about three minutes, in
a 640 µm deep PDMS gasket at a measured height of 480 µm.

The bead velocity remains
constant over time as seen in
Figure 5. Although there are
minor variations in the data,
the F value of an ANOVA
test was 0.816, proving all
the points to be equal within
the 95% confidence level.
This makes sense, given the
FB= j × B rule. If the ion flux
is held constant, and the
magnetic field is constant,
the force and therefore the
velocity should not change
unless one of the other two
variables does, regardless of

the duration of the experiment.
It therefore does not matter when during the course of experiment velocities are taken, as
long as it is before the redox species in the solution is exhausted, thus preventing current from
flowing. The only other condition on time is when the beads, due to the density mismatch of the
solution, sink to the bottom of the cell or rise to the top and stick.
Does it match the theory?
Figure 6: Graph of bead
velocity versus currents
ranging from 10 µA to 35
µA. These experiments
were done in a 620 µm deep
PDMS, at height of 480
µm, and all velocities were
taken five seconds after the
current was first applied.
These measurements show
eight beads per point rather
than four.
If j, ion flux, is
related to i, current, then according to FB= j X B, as current increases in a constant magnetic
field, the force should increase in a linear manner along with it. As shown in Figure 6, this is
indeed the case, but only from ~15 µA to ~30 µA.
At this time it is unknown why this graph does not go through zero. The R2 value of 0.95
indicates some deviation from linearity. Using different conditions to try and get a more obvious
pattern, linear or otherwise, has been attempted, but without success. It is possible that at lower
currents the force is small enough that otherwise minor changes in other variables, such as the
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position of the PDMS gasket, the exact position within the magnetic field, or others could change
the observed velocity noticeably. At higher velocities, the linear trend is more obvious, but at
lower ones, it’s very hard to get reproducible results.
Figure 7: Graph of bead
velocity vs currents ranging
from 10 µA to 80 µA. This
experiment was done using a
concentration of 0.1 M
potassium ferricyanide and
0.1 M potassium ferrocyanide
in order to allow higher
currents to be used, and done
in a 620 µm deep PDMS, with
measured height of 320 µm.

The trend continues to be linear as current increases in Figure 7, showing that i is related
to j. As this figure shows, using higher currents gave a much straighter graph than the original
low-current experiment did. However, it still does not go through zero. There may be a factor
affecting the velocity that we are not taking into account that explains this, but it is unknown at
this time. More experiments of this type are still being done.

Figure 8: Graph of bead velocity vs current at different PDMS depths. The diagram to
the side shows that the measured height was consistent in all depths. The linear
equations for 2500, 1250, 940, and 620 µm deep PDMS are as follows:
2500: y = 2.7407x - 8.1321 R² = 0.9681 1250: y = 2.9893x - 23.168 R² = 0.9641
620: y = 0.6561x + 7.3518 R² = 0.9653
940: y = 1.1386x + 11.289 R² = 0.957
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Figure 8 shows that the depth of the cell similarly does not change the linear trend,
although it seems like current might have more of an effect when a deeper PDMS than they do
when a shallow one is used. More experiments would be necessary to verify this.
What is the overall pattern in fluid flow? Because the ion flux coming straight up or
down off the electrode is perpendicular to the parallel magnetic field, the right hand rule states
that the fluid will flow across the electrode in the same plane as the chip, perpendicular to the
direction of the magnetic field and in opposite directions over the working and counter
electrodes. What was unknown before the start of this project was how the fluid being moved by
that force would be replenished.
A

B

Figure 9 parts A and B: Two possible patterns of fluid movement over the working
electrode. The large dark arrows are the force caused by the ion flux near the plane of the
electrode, and the white arrows are the two ways in which the flow could replenish itself.
The initial expectation was that the fluid would move according to Figure 9A, where the
movement would turn upwards and cycle back around vertically. Fluid here would be fighting
edge effects, which would push downward where the fluid would be trying to go upwards and
upwards where the fluid needed to go down, but because of the large size of these electrodes,
edge effects were thought to be small enough to be easily overwhelmed, especially if the cell
height was very high.
The second expectation, shown in Figure 9B, was that the fluid would move around the
sides of the electrodes to replenish itself, forming two large circles on the same plane as the chip
over each electrode. This pattern would not be fighting edge effects, but would require the flow
to split instead of forming a single circle.
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Figure 10: pictures taken over the counter and working electrodes, showing bead
tracking and movement direction. These measurements were taken in a 2500 µm deep
PDMS gasket, using 0.1 M Ferri/Ferrocyanide, at a current of 100 µA. Rather than an
800 µm working electrode and 2000 µm counter electrode as was used for most
experiments, the working electrode had a width of 2000 µm and the counter 3200 µm.
Because of the increased speed those changes produced, the tracked beads, seen as
outlined dots, here are shown 1/6th of a second apart.

Working

Counter

j

j

−

+

B field direction

B field direction

Figure 10 shows the experimentally obtained flows over the working and the counter
electrode. There are two of them, moving in opposite directions, as the right hand rule predicted.
Regardless of how high or low in the solution where beads speeds are measured, the beads go in
the same direction over the electrode. If there were a vertical circular motion, there would be a
difference in direction between the top of the solution and the bottom of the solution, but this did
not occur. Only horizontal circulations were observed, like those in figure 9B.

Figure 11: Diagram of observed fluid movement over the working and counter electrodes,
viewed from the top down, roughly to scale.
Overall, the fluid forms four large, flat circulations as seen in Figure 11 which meet
between the two electrodes and push away from each other. The observed movement is much
faster over the electrodes than it is circling back around, though this has not been quantified. The
role that edge effects play in any vertical motion, or in keeping this pattern horizontal to the chip,
is unknown at this time, largely due to the bead tracking method not be able to measure vertical
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motion, and also the inability to differentiate between vertical motion caused by edge effects and
that caused by density gradients within the solution. Circulation in the style of Figure 9A was not
observed, regardless of the depth of the cell.
Vertical position and gasket height. The effects of changing the cell depth were
originally explored to see if the fluid flow pattern could be made to flip around and go back over
the electrode to replenish the flow, as seen in Figure 9A. That was not observed; however, large
differences in velocity between the different PDMS heights became apparent, as well as
differences depending on what height the velocity was measured at.

Figure 12: Graph of bead velocity as a function of measured height in the cell. This was
taken from a single, very long experiment in a 2500 µm deep PDMS where the height was
gradually increased by increments of 320 µm until the lid of the cell was reached. The small
diagram to the side shows an approximate cross section of the PDMS, showing where the
measurements were taken as red lines.
The velocity reaches a peak when the velocity is taken at around 25% of the total height
in a 2500 μm cell depth, as seen in Figure 12. Here, the fluid is outside the no-slip boundary, so
resistance is lessened, but the fluid is still relatively close to the electrode providing the force.
This has not been tested in other cell depths, but the pattern was reproducible in the 2500 µm cell
depth. It’s possible that the peak might appear elsewhere in the cell if it were shallower, as the
point where the no-slip boundaries least effect the velocity of the fluid flow would change as the
ceiling got closer or further away.
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Figure 13: Graph of relative bead velocity as a function of the PDMS depth.
These experiments were done at a current of 30 µA. The diagram to the
side shows that the measured height was constant regardless of which
PDMS was being used.
Increasing the depth of the cell decreases the resistance, as the no-slip boundaries become
further and further away from each other, so even at a fixed height within the cell (here 320 μm),
fluid moves faster. As the depth approaches infinity it has less and less of an impact, thus the
graph begins to level out in a logarithmic fashion.

Figure 14: Graph of bead velocity as a function of the PDMS depth
measured at a three different percentages of the total height of the cell. The
three diagrams to the side show the measured heights for the different
The same trend can be observed when the measured height is a percentage of the total
depth, as in Figure 14. Again, the differences between velocities at different heights can be easily
seen, with the measurements closer to the electrode tending to go faster. It is also interesting to
note how the no-slip boundaries, in the thinner PDMS, keep all velocities very similar. As they
get further apart, the beads can speed up as resistance lessens.
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Figure 15: Graph of bead velocity vs PDMS depth at 30 µA, 20 µA, and 15
µA currents.
Even at different currents, the trend of leveling off as the PDMS depth reaches a
maximum continues, though at lower currents it seems to make less of a difference.

Conclusions
The velocity of the beads does not change over time as long as the applied current
remains constant. This fits the relationship defined by FB= j X B, in that when neither ion flux
nor the magnetic field density changes, the velocity does not change. It also implies that
experiments can be taken for very long periods of time without substantially affecting the fluid
dynamics.
There is a linear relationship between current and velocity, supporting that ion flux (j) is
related to current (i). What keeps this relationship from being linear through zero is unknown.
The solution goes around the electrodes instead of up and back over the top in order to
replenish the flow over the electrode, no matter how deep the PDMS gasket is. Whether this is
the result of edge effects keeping the fluid from moving upwards or of something else is
currently unknown. The four circulations this produces are attractive for mixing on a small scale,
or within enclosed spaces where moving parts cannot be easily used.
The velocity of the beads varies through the height of the solution, reaching a peak at
around 25% in a 2500 µm deep PDMS. This is because of the no-slip boundaries at the edges of
the cell, which resist movement and therefore slow the fluid flow near the chip, the walls, and the
lid. The highest velocity is where the fluid is outside the no-slip boundary, but still close to the
electrode providing the ion flux, and therefore the force. This same principle also means that
deeper PDMS will have higher velocities, as the gap between the no-slip boundary at the floor of
the cell and the one at the lid increases, decreasing resistance throughout the rest of the cell. As
cell height approaches infinity, this has less and less of an effect.
These results all add to the fluid manipulation toolkit that MHD has to offer.
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Configuration and Geometry of the RWALP15 Transmembrane Peptide
in a Lipid Bilayer
Jared Kafader, Elmhurst College
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Abstract
Membrane proteins along with their fundamental peptide-lipid interactions are some of the
least understood areas of biochemistry. To answer some of the questions, RWALP15, a
short model transmembrane peptide, was synthesized with isotopically labeled residues
through solid phase peptide synthesis and analyzed by means of 2H solid-state NMR in
various lipid membrane environments such as DLPC (C12:0), DMPC (C14:0), and DOPC
(C18:1). The Geometric Analysis of Labeled Alanines (GALA) was used to determine the
orientation of RWALP15 in each lipid bilayer. Synthesis confirmation of RWALP15 was
determined through MALDI-TOF mass spectrometry and peptide purification was
performed by HPLC. The 2H NMR spectra reveal the RWALP15 peptide does in fact have
a defined orientation in each of the DLPC, DMPC and DOPC lipid bilayers. Circular
dichroism spectra suggest that RWALP15 does contain an α-helix structure in each lipid
system, though immensely diminished in DOPC. Fluorescence emission spectra suggest that
the anchoring tryptophans are located around the lipid/water interface in DMPC, DLPC,
and DOPC. The observed 2H quadrupolar splittings along with the GALA analysis indicate
the tilt of RWALP15 to be ~7˚ in DLPC and DMPC bilayers. It is surprising to observe a
transmembrane orientation of RWALP15 in DMPC considering that the peptide
hydrophobic length appears to be significantly shorter than the lipid bilayer thickness.

Introduction
Membrane proteins as well as their fundamental peptide-lipid interactions are poorly
understood areas due to inherent difficulties in working with membrane proteins. Often smaller
model peptides are employed because they allow investigation of specific interactions under
controlled conditions. Features such as peptide length, residue placement and side-chain
properties that would normally be hard to interpret can be investigated effectively using model
systems. There has furthermore been an increase in the study of antimicrobial peptides because
of the emerging increase of multidrug-resistant bacteria in common antibiotics.1 It has been
found that peptide antibiotics could be useful because they kill bacteria at a rapid rate through the
disruption of bacterial cell membranes. This new form of antibiotics may not be affected by the
drug resistance that past antibiotics have faced.2
Small synthetic amino acid chains have been used to better understand how membrane
proteins interact with lipid bilayers that are mimics with those in cell membranes that are a part
of every cell in the human body. The model WALP series of peptides, Ac-GWW(LA)nLWWA[ethanol]amide, have been extensively used to comprehend this concept.3-6 The comprehension
of membrane proteins are essential to the expansion of knowledge of biological processes,
encoded gene products, and a good number of drug targets that lie within a cell.6 WALP
peptides are often transmembrane peptides with α helical structure.5 Peptides that associate with
the lipid bilayer can normally be described as in one of two states. The first is that the peptide is
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long enough to reside inside or across the lipid bilayer. The amphipathic tryptophan residues at
either end of a WALP peptide can interact with each side of the bilayer, producing an anchoring
and stabilizing effect.5 The second is that the peptide is too short to span the lipid bilayer and
becomes surface-bound. Again using the tryptophans is possible, but this time the tryptophans
would anchor the surface-bound peptide to the outside of the lipid bilayer. In both cases the
tryptophans would be positioned in the lipid head group region near the membrane-water
interface. The lipid bilayer is an important component of biological membranes because it
controls the distribution, organization, and function of bilayer-spanning proteins, which are
significant and imperative to the existence of life.7
RWALP15 contains 15 amino acids chain in the following sequence, acetylGRWLALALALALWRA-amide. (In the one-letter code, G is glycine; R, arginine; W
tryptophan; L, leucine; and A, alanine.) The hydrophobic helical core of leucines and alanines in
RWLAP15 is only about 13.5 Å long and is still only 16.5 Å in length when its tryptophan
anchors are included. The lipids DLPC, DMPC, and DOPC have hydrophobic thicknesses of
about 19.5, 23, and 27 Å, respectively. RWALP15 is
therefore quite short and has both arginine and tryptophan
as possible anchoring residues for a transmembrane
orientation on each end of the peptide. For this project, I
produced the RWALP15 peptide through solid-phase
peptide synthesis. Two different samples were made with
deuterated alanines in different positions. HPLC was
employed to monitor the purity of the peptide, and mass
spectrometry was utilized to measure the molecular mass of
the synthetic RWALP15. Each peptide in fact was designed
to include two deuterium-labeled alanines of differing
isotope abundance levels. These 2H isotope labels along
with solid-state 2H NMR can aid in the determination of the
Figure 1: This 3-D image of RWALP15
illustrates its α-helix configuration and
RWALP15 orientation with respect to the lipid bilayer,
arginine and tryptophan side chain groups.
including the tilt and rotation within the lipid bilayer using
the GALA (Geometric Analysis of Labeled Alanines) method.4,8 In addition, circular dichroism
(CD) spectroscopy was used to determine the secondary structure of the peptide in the lipid
environments, and fluorescence emission spectra were recorded to examine the polarity of the
tryptophan environment.

Methods
Due to the lack of commercially available isotopically-labeled Fmoc-Alanine-d4 for use
in solid-phase peptide synthesis (SPPS), it was first produced.5,9 The chemicals alanine-d4,
manufactured by Cambridge Isotope Laboratories (Andover, MA), triethylamine (TEA)
manufactured by Mallinckrodt (Paris, KY) and N-(9-fluorenylmethyloxycarbonyloxy)
succinimide (Fmoc-ONSu) manufactured by NovaBiochem (San Diego, CA) were used for this
synthesis reaction. Alanine-d4 (445 mg) was dissolved in 5 mL of water plus 5 mmol (700 µL)
of TEA in a round bottom flask. A stir bar was added and placed over a stir place in the hood.
Then 4.8 mmol of Fmoc-ONSu (1.62 g) was dissolved in 5 mL of acetonitrile in a 20 ml beaker
with gentle heating and a stir bar. The Fmoc-ONSu along with the acetonitrile was added to the
round bottom flask all at once and stirred for two hours. During the first 15 minutes of the
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reaction 200 µL of TEA was added as needed to the round bottom flask in order to stabilize its
pH and make sure a pH between 8.5 and 9 is maintained during the two hour stirring period.
After the two hour reaction period the stir bar was removed and the filtrate was concentrated on a
rotary evaporator until the Fmoc-Alanine turned into a viscous yellowish-white gel. Then the stir
bar was re-added and 60 ml of 4.0 N hydrochloric acid was added to the concentrated filtrate. An
extraction with ethyl acetate was performed with 50 ml of ethyl acetate. The aqueous bottom
layer was discarded. The extraction was conducted again with 60 mL of 4.0 N hydrochloric acid
and then followed three more times with 100 ml of water each time. The ethyl acetate layer was
collected in a clean round bottom flask, concentrated under nitrogen, and reduced with the rotary
evaporator, and further dried under high vacuum overnight.9
The Fmoc-alanine-d4 product was recrystallized to improve purity. To do so 50 mL of
ethyl acetate was added to the product in the round bottom flask, and dissolved with stirring and
gentle heating. The product was then filtered through a fine glass filter. The filtrate was
transferred to a recrystallization jar and 15 mL of hexane was added to the mixture. The jar was
placed in the freezer to induce crystallization. After a week in the freezer the formed crystals
were filtered through a 150 mL course glass filter and the filtrate was returned to the freezer for
the formation of another crop of Fmoc-alanine-d4.
100
1
H NMR was performed on the product crystals to
confirm the product collected was fmoc-alanine-d4.
SPPS of RWALP15 – RWALP15 was
synthesized using “Fast-Moc” chemistry on a
Perkin-Elmer Applied Biosystems 433A synthesizer
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(Foster City, CA) using Fmoc-protected L-amino
acids (NovaBiochem, San Diego, CA). Two
deuterium-labeled Fmoc-alanines were incorporated
into each peptide with differing abundances (50%
and 100%). RWALP15 was synthesized first with
Figure 2 : Labeling of one alanine with a
labels on the 5th and 7th position alanine and again
50% deuterium label and the other with a
th
th
with labels on the 9 and 11 position alanine.
100% label and the outcome of their
Side-chain protecting groups were employed for
corresponding NMR splittings.
residues containing potentially reactive side chains
such as Fmoc- Arg-Pbf and Fmoc-Trp-Boc. The Nterminal was coupled with acetyl-glycine to ensure electrical neutrality on each end of the
peptide. During this process, the fmoc-alanine is activated, the resin is deprotected, and the resin
is coupled to the previous residue and then the process is repeated for the next amino-acid in the
chain. TFA Cleavage – A cleavage reaction utilizing trifluoroacetic acid was performed to
cleave the finished peptide from the acid-labile resin as well as remove any side-chain protecting
groups such as the Pbf protecting group on the arginine and the Boc protecting group on the
tryptophan residues.
A TFA cocktail was made consisting of 1.7 mL of TFA, 100 µL of triisopropylsilane,
100 µL of water, and 100 mg of phenol. The TFA solution was added to ~120 mg of RWALP15
resin and allowed to incubate on an orbital shaker for three hours. The cleaved resin and solution
was filtered using a short glass Pasteur pipette with a glass wool and the TFA solution containing
the peptide product was collected. The solution was reduced under nitrogen gas flow to about 1
mL. The peptide was precipitated in 25 ml of ice cold 1:1 Methyl tert-Butyl ether
(MtBe)/Hexane in a 50 mL plastic centrifuge vial by adding dropwise. The solution was left on
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ice for 30 min and after then centrifuged at 4 degrees Celsius for 10 minutes at 1500 RPM. The
supernatant was discarded and the pellet was re-suspended in another 25 mL of ice cold 1:1
MtBe : hexane. This washing process was repeated three more times to remove bulk TFA. The
pellet was then dried under nitrogen and lyophilized from 1 mL acetonitrile : water for 4 times to
remove residual amounts of TFA.
Peptide Quantification – The resulting product was dissolved in 2 mL of TFE and
transferred to a 10 mL vial. The centrifuge vial was then rinsed with another 2 mL of TFE. Two
samples were prepared by mixing 10 µl of peptide solution with 4 mL of methanol. The
absorbencies were then measured on a UV-Vis spectrometer at 280 nm. The average of the two
absorbencies were found and the molar concentration was calculated. From the peptide solution,
a 1 mg/mL solution was prepared for HPLC experiments. A 0.1 mg/mL solution was also
prepared for mass spectrometry. MALDI-TOF mass spectrometry experiments were carried out
at the Statewide Mass Spectrometry Facility by its staff. Peptides in TFE were dried under
nitrogen gas flow down to a film and were lyophilized with 0.5 ml of acetonitrile and 0.5 ml of
water, frozen in liquid nitrogen, and put on the vacuum line overnight.
Purification of RWALP15 - Peptides were purified through HPLC on a Zorbax Semiprep C8 column using a 80/20 to 84/16 methanol/water gradient with 0.1% TFA over 30
minutes. Crude peptide was dissolved into two mL TFE and subsequent 500 µL aliquots were
injected onto the column for separation and collection. UV-Vis monitoring at 280 nm was used
for peptide detection. The collected purified solution was lyophilized three times to remove TFA.
CD and Fluorescence Sample Preparation – About 5 mg of RWALP15 powder was
taken and dissolved in 1.5 mL TFE. Then 20 µL of the peptide was mixed with 980 µl of
methanol and the concentration was determined of RWALP15 through UV-Vis at 280 nm. Then
62.5 mmol of RWALP15 from the TFE solution was transferred into three eppendorf tubes
labeled with DLPC, DMPC, DOPC. Then 3.75 µmol of lipid was added to their respective
eppendorf tubes to make a 1:60 peptide/lipid ratio. The tubes were filmed under nitrogen gas and
put on a vacuum line for 48 hours. The peptide/lipid mixtures were resuspended with 500 µL of
distilled water. The eppendorf tubes were then sonicated for one to two hours until they appeared
transparent. After, the eppendorf tubes were centrifuged for 10 min at 10 thousand rpm and the
supernatant was transferred to new tubes. Each solution was transferred to a 0.1 mm cuvette and
the absorbances were checked on a diode array between 200-300 nm to ensure all values were
under 1.5 AU. The CD samples were made and run utilizing a Jasco J710 spectropolarimeter
(Easton, MD) using 1.0 mm path length, 1.0 nm band width and 20 nm/min scan rate. The
samples were run from 190-250 nm with 13 scans per-sample. The fluorescence samples were
diluted down to 1:10 with water, vortexed well, run, and spectra were recorded on a Perkin
Elmer LS-55 fluorescence spectrometer. Samples were excited at 280 nm and five scans were
collected and averaged.
Oriented NMR Sample Preparation – An oriented glass plate sample with a 1:60
peptide/lipid ratio was produced for solid-state NMR experiments. 1.33 µmol of peptide
dissolved in TFE along with 80 µmol of lipid (either DLPC, DMPC, or DOPC) were transferred
to a single glass test tube. The mixture was put under nitrogen flow to remove the solvents and
placed on the vacuum line overnight. Forty glass slides were arranged over two petri dishes and
1 mL solvent (95% methanol and 5% water) was added to dissolve the peptide/lipid film. Then
25 µL of the peptide/lipid solution was added to each of the 40 glass plates evenly with a
Hamiliton syringe. After, another 150 µL of methanol was added to the test tube and was evenly
dispersed on the 40 glass plates. The glass plates were dried on under the vacuum line in a
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dessicator for two days with a cover to protect the light sensitive samples. Afterwards, 1.2 µL of
deuterium depleted water was added across each slide with a Hamiltion syringe. The 40 slides
were stacked, and placed in a cuvette. Epoxy glue was used to seal a glass lid on the cuvette and
40 minutes later another layer of epoxy was placed over the first layer. The cuvette was then kept
at 40 degrees celcius in a heating block until the samples became clear, which suggest they are
ready for solid-state NMR experiments. P31 NMR was run on each sample to check bilayer
alignment at both =0 and 90, and proton decoupling The scans were run with a 90° pulse rate of
6 µs along with an interpulse time of 5 seconds. All samples were run on a Bruker Avance 300
spectrometer (Billerica, MA) operated at 46.1 MHz with 32 scans at 323K. After the P31 was
run, the 2H solid-state NMR was run and quadrupolar splittings were found at both the β = 90°
and β = 0° alignment using two Bruker Avance 300 spectrometers (Billerica, MA) operated at
46.1 MHz. The scans were run with an interpulse delay of 90 ms, 90° pulse time of 3.4 µs, and
an echo delay of 115 µs with about 800,000 scans run per sample per alignment.

Results
Mass spectrometry was performed on each RWALP15 peptide synthesized to confirm
that the molecular weight of the two samples were in fact RWALP15 plus the weight of the
deuterium labels with a weight of 1730.1 g. The analytical HPLC chromatograms of each peptide
demonstrated that most of the product was
1730.2
the RWALP15, but with small, acceptable
amounts of impurities surrounding it. It was
decided anyway to purify both RWALP15
(2H: A5-50%, A7-100%) and RWALP15
(2H: A9-50%, A11-100%) through the use
1000
1500
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500
4500
2500 3000 3500 4000
0
of HPLC separation and UV-Vis monitoring
to hopefully enable more distinct 2H NMR
m/z
quadrupolar splittings. The CD spectrum
Figure 3 : Mass spectrometry of RWALP15 with
illustrated a peak at 208 nm and another
molar mass of 1722.1 g + 8 g deuterium.
peak at 222 nm, which shows that
RWALP15 does contain an α-helix
configuration. It was concluded that
RWALP15 holds the α-helix character in
DMPC with the highest MRE value at the
wavelength of 195 nm and distinct peaks at
208 nm and 222 nm, closely followed by
DLPC, illustrating that the RWALP15 αhelix is more strained in the DLPC lipid.
The flatter DOPC CD graph shows that
there is probably not much of helix in the
DOPC lipid bilyer and RWALP15 is likely
to surface bound in this situation, perhaps
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not crossing the lipid bilayer. Fluorescence
data demonstrated that RWALP15 in
DMPC, DLPC, and DOPC bilayers with
hydrophobic thicknesses of about 19.5, 23, and 27 Å respectively gave max emission wavelength
Figure 4 : Due to impurities, the RWALP15 crude product was
purified through use of HPLC.
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values at 334.5, 341.5, and 337 nm respectively. These wavelengths are less than the value of
tryptophan in water, which has a fluorescence emission maximum at 355 nm. All 31P spectra for
the peptide-lipid samples run had a strong peak around -25 ppm for ß = 90° alignment and a
strong peak around +25 ppm for ß = 0° alignment, indicating that all 2H NMR samples were
properly aligned in the bilayer phase. Solid state 2H NMR of RWALP15 (2H: A5-50%, A7100%) and RWALP15 (2H: A9-50%, A11-100%) in oriented glass plate samples were recorded
in DLPC, DMPC, and DOPC bilayer lipids. Distinct 2H quadrupolar splittings were observed for
each sample; their values are listed in table 1. Peptide tilt analysis was performed using the
GALA method 6. The GALA results for DLPC show a Szz value of 0.84°, a Tau value of 6.0°, a
Rho value of 252°, an RMSD equal to 0.56 kHz (which indicates an excellent fit), and a epsilon
parallel value for the alanine side-chain geometry of 59.4°. The GALA results for DMPC
illustrated similar results with a Szz value of 0.86°, a Tau value of 7.3°, a Rho value of 243°, an
RMSD equal to 0.25 kHz, and again an epsilon parallel value of 59.4°. The Tau and Rho values
are very similar for DLPC and DMPC, but RWALP15 seems to have radically different results in
the CD spectroscopy and 2H NMR results in DOPC.

Figure 5: The CD results illustrated that RWALP15 resides in a α-helix
configuration in all lipids, but a much smaller amount of helical character,
if any, exists in DOPC, the longest of the lipids.
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Figure 6: The fluorescence data indicate that Trp residues in
RWALP15 are likely found at the membrane interfacial region in
all DMPC, DLPC, and DOPC bilayers. This suggests a
transmembrane orientation, or perhaps a surface orientation with
tryptophans intercalated into DOPC.
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Figure 7: Oriented peptide-lipid samples were first analyzed with 31P NMR to ensure a well oriented bilayer before
running 2H NMR experiments. At β = 0º an aligned sample should have a single peak around +25 ppm and at β =
90º the aligned sample should have a peak around -25 ppm.
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defined orientations in these lipids. Side chain hydrogens
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Figure 8 : This chart illustrates the concepts behind the GALA
(Geometric Analysis of Labeled Alanines) analysis techniques.
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Figure 10 : The experimental data from DLPC and DMPC (shown with
dots) were collected through 2H solid-state NMR and best fit according to
the Δq equation. A best fit curve is shown with the solid line to demonstrate
a specific GALA scenario.
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Discussion
In the CD results, RWALP15 in DMPC lipid has an uncharacteristically stronger signal
than when in a DLPC bilayer. This suggests that RWALP15’s α-helix structure is better suited
for the conditions that are present in DMPC, rather than DLPC, which is unusual. One
speculation for the DLPC value to be lower than its DMPC counterpart is because of the
competition between the arginine and tryptophan anchors on either end of the lipid bilayer
unwinding and perhaps twisting or distorting the α-helix out of an ideal configuration. Further
unwinding of the α-helix in DOPC would not exactly mach the GALA program that assumes that
the peptide entered in its system is an α-helix in shape. The fluorescence data obtained stated that
the tryptophans on either end of the peptide in all DMPC, DLPC, and DOPC are not out in the
water surrounding the lipid bilayer. The fluorescence value for tryptophan in water is 355 nm,
while the values obtained for RWALP15 in DMPC, DLPC, and DOPC are significantly less,
implying that the tryptophans in each situation are somewhat removed from the water. The data
for DOPC having a value that is in the middle of DLPC and DMPC is strange due to the fact that
DOPC has the thickest membrane out of the three lipids. This data might suggest that DOPC is
sitting on the membrane, not spanning it, with its tryptophans inserted in the lipid bilayer. The
solid-state 2H NMR data illustrate that RWALP15 does have defined orientations in or on the
lipid bilayer in DMPC and DLPC, although multiple states may exist in DOPC, as too many
peaks are seen, and different results are observed for the  = 0° and  = 90° sample orientations.
The data also demonstrate that the RWALP15 peptide has a relatively small tilt in the
membranes because all the main alanine side chain quadrupolar splittings are less than 10 kHz
wide, which is not always true but commonly seen in the WALP series peptides. The RWALP15
(2H: A5-50%, A7-100%) purified peptide in DMPC illustrated that the outer side chain peaks
were the A7 position 100% deuterium labeled alanine with a more intense splitting than the
middle peaks, which often receive an extra intensity from residual deuterium in the water. The
HPLC purification process not only made the splittings of the deuterium labels more prominent,
but made the signals of the labels further correspond with their deuterated intensities as well. The
GALA projections as a result of the obtained NMR splittings illustrate that in both situations in
DLPC and DMPC results are similar with a small amount of tilt and rotation in each lipid. These
preliminary GALA results show that there is a small tilt (Tau) of only 6 to 7° and the rotation
(Rho) of the RWALP15 peptide is about 250° in both lipids. There are a multitude of
implications for the specific amount of tilt and rotation that RWALP15 demonstrates and why
they vary from DLPC to DMPC. One reason is because the hydrophobic thickness of both DLPC
and DMPC vary with values of 19.5 and 23 Å. With the core helix of RWLAP15 only being
about 16.5 Å in length between its tryptophan anchors, this creates a mismatch in lengths, with
the peptide trying to span the membranes that are larger than its central region. This difference
can induce bilayer modulation and different peptide tilts to overcome this significant length
difference. DOPC, with a hydrophobic thickness of 27 Å is almost twice the length of the
RWLAP15 core, which can be a reason why the results from this experiment are complicated
and might point to a surface–bound state for RWALP15 in this lipid. With the NMR results
having more than two splittings in at the β = 90° position and rather inconclusive splittings seen
at the β = 0° position, a GALA analysis could not be formulated for RWALP15 in DOPC,
increasing speculation that RWALP15 may be surface bound in this situation.
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Degradation of GDP to Form Apo-Cdc42 wt.
Erika Russell, Bethune-Cookman University
Daytona Beach, FL

Abstract
The goal of the summer research project was to examine possible new ways to liberate
GDP from the protein of interest Cdc42Hs. Two experiments were tried to try to create
apo-Cdc42Hs. First, the fluorescent analogue of GDP was degraded using alkaline
phophatase. Secondly, Cibracon Blue was used as possible affinity matrix due to its high
affinity for ADP-binding proteins and because it binds to ADP it should also bind to GDP.
Furthermore, with apo-Cdc42Hs there will be a better understanding of the structure of
Cdc42Hs which could potentially reveal insights on GDP dissociations and how this leads to
cell proliferation(1).
Figure 1: Cdc42Hs-

GDP(2)

Introduction
Cdc42 wt has 178 amino acids and is one of the first identified human oncogenic
proteins—mutants of Cdc42 wt account for nearly 30% of all cancer cells(1). The Ras family is a
group of related proteins that are involved in cellular signal transduction. As a member of the
Ras family of GTP-binding proteins, Cdc42 wt aids in cellular transformation and cell growth
via increased rates of GTP to GDP cycling(4). When Cdc42 wt is bound to GTP, it is active and
will remain in this state until a GTP-ase activating protein causes it to hydrolyze the phosphate
group body to an inactive GDP state. To return to the active state Guanine nucleotide exchange
factors (GEFs) catalyze the exchange for bound GDP to GTP. This is significant because a
regulatory protein, dbl, has the ability to stimulate the exchange for GDP to GTP in Cdc42 wt
either by increasing the rate of cycling between GTP and GDP, or by a deficiency in GTPase
activity which can lead to cell proliferation and transformation(1). Additionally, Cdc42 wt has a
high affinity for dbl when it is in a nucleotide free state which is why it is important to determine
new ways to liberate GDP from Cdc42 wt in order to begin to study the molecular details of this
form of the protein. One of the new approaches included the potential exploitation of a
chromatographic matrix with an affinity for proteins with a well-defined nucleotide binding site.
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Experimental Procedures
Cdc42Hs was expressed in Escherichia coli BL21(DE3) (Novagen) at 37oC for 3.5 hours.
Protein expression was induced with 1mM IPTG at a cellular density of OD6000.4-0.5. The cells
were disrupted in a French pressure cell (20,000 psi) in 300mM NaCl, 50 mM Tris-HCl, (pH
8.0), 10mM MgCl2, with protease inhibitor (1mM AEBSF, 1x Halt protease inhibitor, 1mM
GDP). The soluble fraction after centrifugation at 20,000 rpm for 30 minutes was subjected to
affinity chromatography on a 5mL nickel column (HisTrap, GE Healthcare, Piscataway, NJ).
The protein eluted from the column at 100 mM imidazole with a 0-to300-mM imidazole linear
gradient over 5 column volumes. A chromatograph of Cdc42Hs being eluted by imidazole can be
seen in figure 1. The imidazole was removed by ultrafiltration. Protein aliquots were lyophilized
and held at -80oC. The concentration of the purified protein was determined by absorbance
spectroscopy (extinction 15,370 M-1 cm-1, at 280nm).
Once the protein was purified two different experiments were attempted to try to
accomplish the same goal—the generation of apo-Cdc42Hs. In the first experiment the goal was
to unfold Cdc42Hs using a buffer containing Urea, and to refold without GDP. To begin
parameters were established using a control protein Pyruvate Kinase and a Cibracon-Sepharose
Column. The protein was selected because it possesses a dinucleotide fold and because of this it
should bind well to the Cibracon blue dye. This is believed because Cibracon Blue dye is
covalently attached to the Sepharose matrix(7-8) and can be used to have a greater affinity for the
binding sites of proteins with a dinucleotide fold like Pyruvate Kinase and Glutamine Synthetase.
This is important to try because if it works then we can also try to bind Cdc42 wt to exploit
potential binding affinity of Cibracon Blue. Consequently, in the control experiment the control
protein Pyruvate Kinase was added to a cibracon-sepharose column. The column was
equilibrated with 20mM Tris-Base buffer pH 7.5, followed by adding 300mM of NaCl pH 7.5
(via a gradient) to elute the protein(4). A picture of what this should look like can be seen in the
chromatograph in figure 3. The goal was to elute the protein using NaCl and confirm that the
protein came off the column by gel electrophoresis. The hope was that once this was
accomplished we could then place the sample containing protein, GDP, EDTA, DTT, Mg2+,
and Urea (to unfold protein) into dialysis tubing in PBS buffer(4). Place dialysilate on column and
elute using imidazole. Finally, add apo-Cdc42Hs to cibracon-sepharose column.
In the second experiment a fluorescent analogue of GDP—Mant GDP was added to a
buffer containing 64mM Tris-HCl, pH 7.6, 1mM EDTA, 1mM NaN3(5). Subsequently, dry
alkaline phosphatase (200µL) beads were added to the Mant-GDP-Buffer, and the reaction was
observed over 2 hour period of time—taking readings (200μM of Mant-GDP buffer and 800μM
buffer) every 20 minutes using the fluorometer (This was important to try because if alkaline
phosphatase degraded the fluorescent analogue of GDP then it should also degrade GDP in
Cdc42Hs). Once this is accomplished GDP was exchanged for GMPPCP. Alkaline Phosphatase
reduced GDP to guanosine, (which can be monitored on the FPLC) and after a full GDPGMPPCP exchange is believed to have occurred phosphodiesterase will be added to degrade
GMPPCP and leaving Cdc42Hs nucleotide free(5) and ready to be added to the CibraconSepharose column.
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Data Collection and Analysis:

Figure 2

Figure 3

Figure 2 shows a chromatograph of Cdc42Hs being eluted by imidazole using the FLPC
(2L of culture yielded 2ml of pure Cdc42Hs). There were a lot of setbacks that prolonged the
process of protein purification. An extensive amount of time was spent on the preparatory work
to attempt to purify Cdc42Hs. First, DNA had to be extracted from E. coli cells and a
transformation was performed in competent E. coli cells. A transformation is done by prewarming the water bath to 42oC, incubating plates at 37o C, and adding 1 µl of DNA to the
culture. Proceed by adding 20µl of BL21 DE3 and placing in water 30 second. Next, insert LB
miller broth into each sample, mix gently, and place in shaker for 45 minutes (200 rpm and 35o
C). Centrifuge for 5 minutes at the maximum speed, insert 100 µl of LB miller broth into each
sample, and decant 100µl of LB miller broth followed by 50µl of sample onto agar plates. Use
cell spreader to spread across each plate and allow growing over night at 37o C in incubator.
Once this process is complete perform a test expression via gel electrophoresis that allows for
verification that the protein has been expressed. If an ample of amount of protein is visible in the
gel then the protein is amplified. If the protein results do not show this then the process is
performed again with new DNA, which was done numerous times until we finally attained
adequate test results via gel electrophoresis. Figure 3 shows gel electrophoresis confirming pure
Cdc42 wt. The samples were collected from the fractions that correspond to the peak in figure 2.
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Sample fractions
were collected

NaCl was
Figure 4
Figure 4 shows a Chromatograph of Pyruvate Kinase from Cibracon Sepharose column.
Sample fractions were collected and tested using gel electrophoresis, however we did not see any
bands at 25Kda (molecular weight of pyruvate kinase) so we could not confirm that this is the
protein. Consequently, some experimental error could be involved; especially because obstacles
arose from the fact that the amount of protein necessary to be able to observe the protein is
unknown. Therefore, the challenge was to successfully bind enough protein to the cibraconsepharose column to visibly observe the presence of protein via gel electrophoresis—which did
not occur.

Results and Discussion

Figure 5
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In figure 5, Alkaline Phosphatase was added to Mant-GDP buffer. The reaction was
observed over 1 hour period of time—taking readings (200μM of Mant-GDP buffer and 800μM
buffer) every 20 minutes using the fluorometer. The graph showcases the intensity decreasing
significantly because GDP is degraded by Alkaline Phosphatase.
Figure
6

Figure 6 is a continuation of figure 5, here ΔF is the change in fluorescence relative to the
initial fluorescence, where the initial value is the 10 minute reading and the final value is the 80
minute reading. This graph further illustrates what is being displayed in figure 4, that at about 50
minutes GDP is degraded.

Conclusion
In Figure 4, for the first 50 minutes the intensity steadily decreases starting at 60,000 and
dropping to 25,000—after 50 minutes the intensity fluctuates indicating that GDP was
completely degraded after about 50 minutes. However, we were unable to repeat experiments to
establish a trend in the potential noise after 50 minutes or if another excited state process was
being exploited from an emission stand point. From this information there is reason to believe
that because Alkaline Phosphatase degrades the fluorescent analogue of GDP then it should also
degrade bound GDP in Cdc42Hs.
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A Kinetics Study of Cytochrome C and Cytochrome C Oxidase
Maria Williams, Texas Southern University
Houston, Texas

Abstract
The basis of my experiment is to the study the reaction of cytochrome c and cytochrome
oxidase using site-directed mutagenesis and steady-state kinetics. The goal was to
characterize the electrostatic interaction between cytochrome c and cytochrome oxidase.
The mutants that were expressed in this project were E89T/E90Q and E89T/E90K. These
mutants replaced the native negative charge on glutamic acid 90 [E90] with a neutral
charge, glutamine [Q], or a positive charge, lysine [K]. By gathering data from the kinetic
experiments, we will be able to determine if the mutations had an effect on the reaction
between cytochrome c and cytochrome oxidase. Steady-state kinetics generally displays
saturation kinetics at sufficiently high cytochrome c concentrations and often obeys
Michaelis-Menten kinetics with a Michaelis constant, Km, and a maximum velocity, Vmax
[2].

Introduction
Electron-transfer reactions play an essential role in biological processes such as
mitochondrial respiration. Cytochrome c and cytochrome c oxidase are two major components of
the electron transport system (Figure 1). Cytochrome c is an electron carrier outside of the
mitochondrial membrane shuttling one electron at a time from complex III to complex IV. It
contains a heme group with two axial ligands, one His-N and one Met-S, giving octahedral
coordinates to the iron atom. The two iron oxidation states are Fe (III) d5 and Fe (II) d6 [4].

Figure 1. Mitochondrial Respiratory Chain
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Cytochrome oxidase is a large membrane-bound enzyme with each half of the dimer
consisting of 13 polypeptide chains. The complex acts as a terminus of mitochondrial electron
transport in aerobic life, by using four electrons to reduce dioxygen. A series of metalloprotein
complexes embedded in mitochondria or bacteria utilizes electron transfer reactions to pump
protons across the membrane and create an electrochemical potential (Figure 1) [1]. In each half
of cytochrome oxidase there are three metal sites that involve electron transfer: bimetallic Cua
monometallic cytochrome a, and bimetallic heme a3/Cub (Figures 1,2). Cytochrome c initiates
electron flow through the enzyme by delivering one electron at a time to Cua, which sits just
outside of the membrane. Electrons flow from Cua, though cyt a to a3/Cub, which is where O2 is
bound and reduced to water [6]. Two sources of electrons are known for the ETS, namely
nicotine adenine dinucleotide (NAD) and flavin adenine dinucleotide (FAD). Reduced NAD
transfers electrons to complex I and FAD transfers electrons to succinate dehydrogenase
complex (complex II).

Figure 2. Complex between Cytochrome c and Cytochrome Oxidase
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Oxygen serves as the terminal electron acceptor, oxidizing the heme a3/Cub binuclear
center in cytochrome oxidase. Electron transport inhibitors act by binding one or more redox
centers, preventing electron transfer directly [3]. Changes in the chemiosmotic gradient are used
to control electron transport, and only two electron entry points in the electron transport chain are
known to be used in the mitochondria. An inhibitor may completely block electron transfer by
irreversibly binding to a redox site. For example, cyanide binds with cytochrome oxidase so as to
prevent oxygen binding and reaction. Electron transfer is reduced to zero.
The overall goal of my experiment was to the study the reaction of cytochrome c with
cytochrome oxidase using site-directed mutagenesis and steady-state kinetics. The specific aim
was to characterize the electrostatic interaction between cytochrome c and cytochrome oxidase.
The mutants that were expressed in this project were E89T/E90Q and E89T/E90K (Figure 3).
These mutants replaced the native negative charge on glutamic acid 90 [E90] with a neutral
charge, glutamine [Q], or a positive charge, lysine [K]. By gathering data from the kinetic
experiments, we will be able to determine if the mutations had an effect on the reaction between
cytochrome c and cytochrome oxidase.

Figure 3. Complex between Cytochrome c and Subunit II of Cytochrome Oxidase
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Experimental Procedure
The mutants that were used in the experiment are labeled as E89T/E90Q and
E89T/E90K. The mutants were expressed in XL21BE3 native E.coli cells using plasmid DNA
strands with the selected mutations which will grow and express. The mutants were expressed in
rich broth for a forty-eight hour period and were spun down in the centrifuge to get the protein
into solution. Once all of the rich broth is gone the cells were lysed and the protein purified. The
purification process included ammonium sulfate precipitation, size exclusion chromatography,
and high pressure liquid chromatography (HPLC) using a cation exchange column. The protein
was highly pure after the HPLC. The protein still had a high concentration of salt, so it was
exchanged with 5 mM sodium phosphate pH 7, using a centrifuge concentrator. The protein was
then used for the kinetic studies. The kinetics was started by measuring out .08705 grams of
sodium dithionite and 5 milliliters of water to make .1M of solution which is made anaerobic.
The stock solution of oxidase was diluted by a 1:100 ratio, so 3 uL of oxidase was diluted with
300 uL of buffer. The buffer was 5 mM sodium phosphate/100 mM NaCl .01% lauryl maltoside,
pH 7 at 25 C. For each experiment, a concentration of cytochrome c was placed in 500 uL of
buffer and degassed. The concentration was then measured on the degassed sample and on
average 3 to 5 μL of sodium dithionite was added to the sample to fully reduce cytochrome c.
The spectra were checked again to see if cytochrome c was fully reduced. Once this had
happened, the top was opened to check to see if the spectra remained stable. The amount of
oxidase was measure out by calculating the concentration of the oxidase stock. On the days the
experiments were conducted, approximately 5 nM cytochrome oxidase was used. Then the
required amount of oxidase was added to the sample and the rate of oxidation of cytochrome c
was measured at 550 nm in the spectrometer. This was repeated many times to obtain data for
the experiment.

Results and Data Analysis
In (Figure 4), the E89T/E90Q mutants coming off the cation exchange column of the
HPLC in a highly pure state. The highest peak in the chromatogram represents the time it took
the pure protein to elute off of the column.
In (Figure 5), at approximately 550 nm, the spectrometer is reading that the E89T/E90Q
mutant has been completely reduced at this peak.
In (Figure 6), the transient graph shows the reduction of E89T/E90Q mutant with
cytochrome oxidase.
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Figure 4. HPLC Chromatogram of E89T/E90Q

Figure 5. Visible Spectra of E89T/E90Q
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Figure 6. Reduction of E89T/E90Q cytochrome c by cytochrome oxidase monitored at
550 nm.

Kinetics of Reaction of cytochrome c mutants with cytochrome oxidase

07/15 Human Cyt c Wild Type
Vmax= 4.76
Concentration uM
1.13 uM
3.38 uM
4.8 uM
8.2 uM
18.2 uM

Rate s-1
0.678
0.792
1.62
2.60
2.61

07/15 E89T/E90Q
Vmax= 2.74
Concentration uM
3.6 uM
8.34uM
10.5 uM
14.2 uM
22 uM

Rate s-1
0.876
1.25
1.44
1.92
1.81

07/15 E89T/E90K
Vmax= 2.04
80

Concentration uM
2.2 uM
5.4 uM
12.3 uM
16.4 uM
25 uM

Rates s-1
0.831
0.894
1.62
0.918
1.29

07/16 Human Cyt c Wild Type
Vmax= 3.20
Concentration uM
1 uM
2 uM
3.4 uM
5 uM
8.7 uM
13.4 uM
17.9 uM

Rates s-1
0.756
2.03
1.42
2.39
1.30
2.01
1.52

07/16 E89T/E90K
Vmax= 2.47
Concentration uM
1.88 uM
3.85 uM
4 uM
9.12 uM
12.33 uM
18 uM

Rates s-1
0.700
0.576
1.26
1.48
2.00
1.72

Discussion
The goal of our experiments was to determine the effect of replacing the native negative
charge of the glutamic acid [E] of position 90 of cytochrome c with a neutral charge, glutamine
[Q] and a positive charge lysine, [K]. The E98T/E90Q mutant expressed well and that allowed us
to collect a large amount of protein for kinetic experiments. The E89T/E90K mutant did not
express well but we did obtain enough for the kinetic experiments.
The reaction of cytochrome c with cytochrome oxidase obeyed first-order kinetics at all
concentration of cytochrome c. The results of my experiments were that at lower cytochrome c
concentration, the first-order rate constant was larger, and at higher cytochrome c concentration
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the rate constant became smaller. The experiments were conducted on two consecutive days.
Over the two day period we were able to gather data to plot on graphs but the 07/16 E89T/E90Q
data was too scattered to plot. The objective in plotting the points is a trend line to get values for
the Vmax.
In summary, the Vmax of both the E89T/E90Q and E89T/E90K mutants was smaller than
that of wild-type cytochrome c, indicating that residue 90 plays a role in the interaction between
cytochrome c and cytochrome oxidase.

Conclusion
The data that was collected indicated that E89T/E90Q and E89T/E90K mutants had a
smaller Vmax than that of the human cyt c wild-type. The residue 90 plays an essential role in the
reaction between cytochrome c and cytochrome oxidase. For a significant conclusion, there was
not enough data to conclude that the E90Q and E89T/E90K mutants bind tighter to the
cytochrome oxidase. The oxidase was placed on ice for the duration of the project but once a
concentration of cytochrome c has been taken the activity of the enzyme may need to be checked
also for stability.
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Analysis of [6,6]‐phenyl C61‐butyric acid methyl ester (PCBM) by FTMS
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Overview:
Optimal sample preparation protocol was developed for Matrix Assisted Laser
Desorption/Ionization Fourier Transform Mass Spectrometry (MALDI‐FTMS) analysis of
[6,6]‐phenyl C61‐butyric acid methyl ester (PCBM, C72H14O2) by comparing different
matrices, matrix:analyte ratios and sample deposition methods.

Data & Discussion:.
Figure 1: MALDI‐FTMS spectrum of PCBM; matrix‐dithranol, molar matrix:analyte ratio
250:1, laser power 50%.

Laser power influence was investigated and the optimum value was established.

Figure 2: Enlarged section of the spectrum shown in figure 1.

Resolution:132,000
S/N: 1446

Laser Desorption/Ionization (LDI) FTMS analysis of PCBM was carried out as well and
results were compared to those produced by MALDI‐FTMS.

Good resolution
Good signal to noise
Good peak intensity
Aerospray technique yields best results
Optimal matrix:analyte ratio is 250:1 for dithranol
The least amount of fragmentation and the preferred
matrix of choice for PCBM analysis

Introduction:
Organic photovoltaic (OPV) cells commonly use PCBM as an electron‐accepting
material, however it undergoes degradation under service conditions.
The investigation of degradation kinetics of PCBM and other components of OPV
devices by laser ionization mass spectrometry techniques (such as MALDI and LDI) is
the final goal of this project.

Figure 7: Illustration of PCBM ion generation and the reason for the appearance of double
peaks.

[PCBM]

[PCBM]
[PCBM]

[PCBM+H]

[PCBM+nO]
+nO

[PCBM+2H]
[PCBM+3H]

[PCBM‐H]

Fourier Transform Mass Spectrometry (FTMS) was used to analyze PCBM. FTMS uses
an image current generated by the ion’s cyclotron frequency to generate the mass
spectrum by a mathematical process called the Fourier Transform.

[PCBM‐H]

[PCBM+4H]

[PCBM+2O+H]

In this preliminary study pure PCBM was analysed using LDI and MALDI ionization
methods in order to establish optimal sample preparation protocol. Several molar
matrix to analyte ratios (250:1, 500:1, 750:1, 1000:1, 2000:1, 5000:1) were compared
as well as two different matrix compounds – dithranol and 9‐nitroanthracene. The two
methods of sample deposition (dry droplet and aerospray) were compared as well.

[PCBM+4O+H]

[PCBM+O]+

[C60]
[C70H11]

+n13C

[PCBM+nH+nO]


[PCBM+n13C]

[PCBM‐H+nO]

[PCBM+3O+H]
[C39H72]

+nH

[PCBM]

+nO

[PCBM+O+H]

MALDI is a soft ionization technique in which the analyte is mixed with a large excess
of a matrix compound and deposited on the target plate. After deposition on the plate,
the sample is exposed to the short laser pulse and is ionized with the assistance of the
matrix compound which absorbs and dissipates the energy from the laser. Another
laser ionization method is LDI, which is an ionization process similar to MALDI except
without the use of an organic matrix as an energy buffer.

‐H

+nO
[PCBM+nH]

[PCBM+2O]

[PCBM+5O+H]

[PCBM+4O]

[PCBM+5O]

[PCBM+3O]

Figure 8: Composite summary of absolute peak intensity of PCBM at various
molar matrix to analyte ratios.
Figure 3: MALDI‐FTMS spectrum of PCBM; matrix‐9‐nitroanthracene, molar matrix:analyte
ratio 750:1, laser power 50%.

Experimental:

5.0E+07

In te n s.
x1 07

Resolution: 136,000
S/N: 206

Instrumentation and analysis:
Mass analysis was performed using the positive ion mode of a 9.4T Bruker Ultraflex
FTMS with external ionization source and utilizing a Nd:YAG laser (operating at 355
nm). Each spectrum represents an average of 35 scans, each using 30 laser shots.

Figure 4: LDI spectrum of PCBM, laser power 50%.

[PCBM]

Dithranol (Aerospray Technique)
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9-nitroanthracene (Aerospray Technique)
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1 .2

Absolute Intensity910.1

The spectra were calibrated with external peptide standard II mixture using matrix ‐
cyano‐4‐hydroxycinnamic acid (CHCA). The peptides Angio 21, Angio 1, and SubsP were
used as calibration points.

4.0E+07

[C60]

Good resolution
Poor signal to noise
Poor peak intensity
Aerospray technique yields best results
Optimal matrix:analyte ratio is 750:1 for 9‐
nitroanthracene
More fragmentation than dithranol and not a
preferred matrix for PCBM analysis.

For spot‐to‐spot reproducibility analysis, experiments were performed as triplicates,
collecting spectra from different spots on the target plate.

1 .0

0 .8

Sample preparation:
Both PCBM and matrix compounds (dithranol, 9‐nitroanthracene) were dissolved in
toluene and mixed together.

[C67H5

8 0 9 .0 3 6 8 4
0 .6

]

3.5E+07
3.0E+07
2.5E+07
2.0E+07
1.5E+07
1.0E+07
5.0E+06

Several molar matrix to analyte ratios were composed: 5000:1, 2000:1, 1000:1, 750:1,
500:1, 250:1.

0 .4

0.0E+00
[C67H5O]

For the dried droplet deposition method, approx. 1 l of the matrix‐analyte mixture
was deposited on the stainless steel target plate and allowed to air dry.

[C39H72]

[C60]

[C70H11]

250-1

[PCBM]

500-1

750-1

1000-1

Matrix:Analyte Ratios

0 .2

9 1 0 .0 9 7 1 3

For the aerospray deposition method, aerosol particles produced from approx. 50‐100
l of the matrix‐analyte mixture were deposited on the stainless steel target plate.

4 5 2 .3 3 6 9 1
5 8 2 .4 5 7 2 0

9 8 7 .6 1 1 6 5 1 0 3 6 .3 5 0 6 5

6 4 0 .2 1 9 6 4
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Figure 5: Laser power influence on the PCBM signal intensity (matrix‐dithranol)
A – Dried droplet technique
B‐ Aerospray technique

50 0

6 00

7 00

800

90 0

100 0

m /z

Figure 6: Laser power influence on the PCBM signal intensity (matrix‐9‐nitroanthracene)
A – Dried droplet technique
B‐ Aerospray technique

A

B

The use of dithranol as a matrix at matrix:analyte ratio of 250:1, and aerospray
deposition technique at a relative laser power of 50% produced spectra with the
highest PCBM signal yield, highest signal‐to‐noise ratio and minimal amount of
fragmentation.

B

A
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 Aerospray deposition method was proven to produce spectra with higher spot‐to‐
spot reproducibility.

7.0E+06

7.0E+05

Conclusions:
Formation of various hydrogenated and oxidated derivatives of PCBM was
observed and the species were identified.

4.5E+07
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Future Considerations:
NMR analysis of PCBM sample is needed to clarify whether the oxidated species
are being formed during mass spectrometry experiment or are the evidence of
sample degradation.
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Accurate measurement of the laser power and shot‐to‐shot reproducibility is
needed to quantify obtained results.
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Exploring New Reactivity of 2H-Azirines in Metal Catalysis and Organocatalysis
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We Proposed:

Azirines Used in the Study

Background and Information
• Two isomers of azirines are known to exist:

H
N

N

Br

Et3N, DCM
OH

O

11
(synthesized through Sequence I )

N

Br

F

F
F

O

12

F

Cl

1H -azirine
• 1H-azirines are anti-aromatic and much less stable than 2H-azirines.
• 2H-azirines possess a highly reactive nature influenced by their ring strain, making them useful
precursors to synthesize more elaborate heterocycles3. However, they have been seldom studied in
organocatalysis.
(3) Palacios, F.; de Retana, A. M. O.; de Marigorta E. M.; de los Santos, J. M. Org.
Int. 2002, 34, 219.

Me
O

Me

• Azirines are the smallest unsaturated heterocycles.

F

F
F

(synthesized through Sequence II)

F

F

metal catalyst
THF

F

New Reactivity of 2H-Azirines
Me

Prep. Proced.

Me

Me

We Proposed:

Br

Goals

13

We were interested in exploring the new reactivity of 2H-azirines with the aim of developing a new
catalytic method for the synthesis of pyrrolidines with up to four continuous stereocenters. We
proposed that with the assistance of a secondary amine such as L-proline, 2H-azirines would react
with enals to create the desired pyrrolidine derivatives. Our group has recently developed a catalytic
method for the synthesis of indoles from 2H-azirines. To increase the efficiency of this method, we
were also interested in synthesizing indoles directly from the pentafluorobenzoates of oximes hence
bypassing 2H-azirines as the intermediate.

N
H

Br

N

Br

N

Results Obtained:
Table 1. Catalyst Screening

Experimental
Synthesis of 2H-Azirines
entry
1
2
3
4
5
6

Results Obtained:

catalyst (mol %)
CuCl (50)
CuCl2 (50)
CuTC (50)
[CF3SO3Cu]2·C6H5CH3 (10)
FeCl2 (50)
FeCl3 (50)

13, yield (%)
0a
0
0
0
0
0a

Conclusion
In conclusion, we have not yet been able to synthesize the pyrrolidine derivatives as we had proposed since
in the observed reactions, 2H-azirine was completely recovered. We have not been able to obtain indoles
directly from the pentafluorobenzoates of oximes either. However, we observed several byproducts in the
screening experiments, one of which we identified was ketone 14..
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N
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+
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Computer Modeling of the Thermal Rearrangement of 2‐aryl‐2H‐azirines to Indoles
Vernon D. Crowell and Peter Pulay
University of Arkansas, Fayetteville
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Scan from Nitrene to Azirine complex

‐2858.96

Introduction:
Indoles see wide use in the pharmaceutical industry and are a common
bioactive natural product. This has driven chemists to develop more
effective ways of synthesizing indoles. Dr. Zheng and his lab have
worked on a method utilizing the thermal rearrangement of 2‐aryl‐2H‐
azirines to indoles. Past experiments used various palladium or
rhodium catalysts, but Dr. Zheng’s lab sought to find a less expensive
catalyst. The lab’s experimental work discovered that only iron(II)
chloride catalyzed the reaction, and only when the reaction occurred
in THF. In order to supplement the experimental work, a theoretical
study of a proposed catalytic cycle was performed.
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R: Reactant(Fe(II) complex omitted)
IM1: Azirine‐Fe(II) complex
TS1: Azirine C2‐N bond broken
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TS2: C(Ortho)‐N bond formation
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TS3: H‐migration and aromitization
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Jana, Samaresh; Clements, Mack D.; Sharp, Barry K.; Zheng, Nan. “Fe(II)‐Catalyzed Amination
of Aromatic C‐H bonds via Ring Opening of 2H‐Azirines: Synthesis of 2,3‐Disubstituted Indoles.”
Accepted for publication by JACS.
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Purpose:

‐44.96

Scan of closing C‐N bond distance to form indole

‐50

‐2858.95

Initial Reaction:
Calculations were performed at the B3LYP level of theory using the
moderately sized m6‐31g‐d basis set. The initial catalyst was assumed
to be the high spin, tetra‐coordinated iron(II) complex shown in the
reaction below.

‐2858.96

Energy (Hartrees)

The purpose of this project is to use computer modeling to supplement
experimental work on the catalyzed thermal rearrangement of a
2H‐azirine to a 2,3‐disubstituted indole. A possible catalytic cycle
involving a tetra‐coordinated iron(II) complex was modeled at the
B3LYP level.

Hydrogen as substituent on
C2:

‐2858.97

When hydrogen is the substituent on C2 of the azirine ring, experiment
shows that the rearrangement doesn’t occur in the time allowed for the
reaction. This is most likely due to the conjugation shown in the azirine
ring system with hydrogen in the system, as the carbon‐carbon bond in
the azirine shows some double bond character. The azirine reactant
with hydrogen as a substituent is more stable relative to the
intermediates and transition states, raising energy barriers and thus
increasing reaction time.
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Scan of closing C‐N bond
distance to form indole
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Findings:
Initially, the 2H‐azirine displaces a THF from Fe(THF)2Cl2, a process
that is endothermic by 1.48 kcal/mol. In the next step, the
unusually long bond between the azirine C2 and nitrogen is cleaved
to form a vinyl nitrene complex. From the nitrene complex, a non‐
aromatic indole tautomer is formed when the bond distance of the
N‐C(ortho) bond shortens. The next step involves the migration of
hydrogen from the ortho carbon to the nitrogen, a process resulting
in aromatization and a weakening of the nitrogen iron bond. The
FeTHF(Cl)2 is then expelled, resulting in the indole product. The
substitution of hydrogen with the methyl group on C2 results in a
relatively more stable reactant, which increases energy barriers and
reaction time.

+ THF

Transition State Search and
Verification:
After optimizing the geometries of reactants and the initial
intermediates, approximate transition state geometries were found by
scanning the coordinate of importance to that reaction step. In this
catalytic cycle, various carbon‐nitrogen bonds were scanned and the
geometries optimized while constraining the bonds to certain lengths.
After optimizing the approximate transition state obtained from scans,
the transition state is verified by running a frequency calculation. A
true transition state will have only one imaginary frequency, and this
frequency can be verified as the true transition state by viewing the
vectors corresponding to this frequency. The vectors with the largest
magnitude should correspond to the variable being scanned.
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Methods towards thiazolium salt rearrangements
Rebecca Foos, Silvana Dormi, Matt McIntosh*
University of Arkansas, NSF REU
Abstract: Much of research within organic chemistry surrounds the methods of
pharmaceutical development. The compound thiazole is considered to be a favored structure
in many drugs, and as such methods by which it may be used synthetically are of great
interest. This study develops the chemical rearrangement of an n‐allyl substituted thiazole to
a terminal alkylene chain at the beta carbon. Although the study is ongoing, successful
rearrangement has been observed with yields up to 38%.

Thiazole is known as a “privileged” structure in the chemi‐pharmaceutical world due to its
heavy use in drug syntheses. Fig. 1 shows several such drugs. Of course any molecule of this
size takes many synthetic steps to produce. For this reason, the synthetic rearrangement
developed in this study is of great practical value in the field of pharmaceutical development.

Following the salt formation, activation by base at the beta carbon by
sodium hydride gives the ketene acetal intermediate.
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This process, without the interference of an allyl group, has been
previously developed; however, there is a known side product which
must be avoided. Fig. 4 shows the process known as dimerization,
which gives an observed side product within the intended synthesis, a
dimer of the original salt.
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The side reaction may be avoided via very high dilution of the reaction
mixture, with essentially serves to isolate the formed ketene acetal
from the unreacted salt.

Fig. 1a-d

A close predecessor to this rearrangement is found in the Kurth reaction of the 1980s, which
saw the same rearrangement with an oxygen replacing the sulfur. However, this reaction was
not intended for pharmaceutical application, but instead served as a method towards
enantiomerically selective production of a carboxylic acid.

The first step in the rearrangement synthesis is the formation of the base salt (see Fig. 2). By
heating thiazole with an allylic electrophile – we used tosylate – for up to five hours, followed
by purification via trituration in ether, yields of up to 86% were reached.
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This may be achieved in two ways:
1) by adding the salt in solution very slowly by syringe pump to a hot
reaction mixture, which will presumably allow the ketene acetal to
immediately rearrange upon formation, with low enough
concentration that it will not kinetically be able to react with any
unreacted salt
2) by using a solvent in which the salt is insoluble, thereby limiting the
presence of salt with ketene acetal in solution by the innate solubility
of the salt. This second process also allows for complete reduction to
the ketene acetal and subsequent heating to drive the rearrangement
in a two step process, giving a bit more control and observability.
Via the second method, the procedure for the total rearrangement
becomes rather straightforward. The salt is placed in toluene in a
pressure tube to prevent the toluene from boiling off during heating.
Sodium hydride and tetramethyl guanidine (TMG), a base facilitating
the proton transfer, are added to the solution and the ketene acetal is
formed at room temperature over a period of 20 hours.
At twenty hours, the reaction is placed in an oil bath and heated to
150 C for 2 hours.
Purification via extraction in ether and column chromatography gives
the final pure rearrangement product, verified by Nuclear Magnetic
Resonance (NMR) Spectroscopy (see Fig. 5)

The clean spectra detailed above shows the purity of the
rearrangement product at above 90%. This particular reaction gave a
yield of 38%, which in the initial stages of development is rather high.
Further study will include labeling of the terminal rearrangement
carbon via a methyl group to check positively that the mechanism is
indeed a rearrangement and not simply a electrophile/nucleophile
intramolecular reaction.
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Fluid Motion with Magnetohydrodynamics

Amanda Hicks, Melissa Weston, Joe Bruton, and Ingrid Fritsch
Department of Chemistry and Biochemistry, University of Arkansas, Fayetteville, AR 72701

Background and Introduction
FB= j X B defines the magnetohydrodynamic (MHD)
force, which is related to the Lorentz force.

•To understand the way the magnetohydrodynamic force moves fluid containing
a redox species in a small volume using a magnetic field parallel to the chip rather
than a perpendicular one as has been done in the past.
•To learn the different factors that affect the velocity of the beads.
•To find out whether the fluid goes around the sides of the electrodes or up and
over them to replace the fluid that is moving away.

Data, Results, and Interpretation
Does it match the theory?
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•Chronopotentiometry was used to control the current
within the cell, using a gold working, reference, and
counter electrode of 800 µm, 200 µm, and 2000 µm
respectively.
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Graph of relative bead velocity over three
minutes,
showing
velocities
remaining
unchanged over time.

Answer:
No. When using a controlled
current, the velocity remains
constant over time. This means
that there is a broad window of
time for measurements without
changing the results, until the
ions in solution are exhausted.

Graph of bead velocity at different currents
showing a linear trend consistent with the
movement within the perpendicular field. It
is important to note that it does not pass
through zero, but the reason for that is not
known at this time.
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What is the overall pattern of the fluid flow?
FB= j X B
j, ion flux, is related to i, which is
applied current.
Therefore, higher currents should lead
to higher velocities.

field direction
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Does time matter?

Velocity (µm/s)

•A solution of 0.07 M potassium ferricyanide, 0.07 M
potassium ferrocyanide, and 0.1 M potassium chloride,
with a 50X dilution of 10 µm polystyrene beads in deionized
water was prepared.
•Polydimethylsiloxane (PDMS) gaskets placed on the chip
were used to determine the depth of the cell (the cell being
the electroactive solution surrounding the electrodes.)

Velocity (µm/s)

Methods

Purpose
Potential applications include microfluidics, or lab on a chip type applications.
The MHD force is capable of moving fluid without the use of moving parts,
and could be used for pumping, mixing, or stirring within a small, enclosed
environment.
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Different currents at different PDMS depths continue
to follow a linear trend, proving that the relationship
holds.

Answer:
Yes. The relationship between current and bead velocity is linear,
following the relationship of j being represented by i.

Top down view of flow between working and counter electrodes
showing the reversal of the fluid direction between the electrodes
Answer:
The fluid moves in opposite directions over the working and counter
electrodes, forming four circulations across and around the electrodes
instead of going up and over. The right hand rule predicts this if edge
effects are ignored. Moving counter electrodes does not affect patterns.

Vertical position and PDMS depth
80

70
60
50
40
30
20

0
0%

20%

40%

60%

80%

100%

Percent height

Diagram of the measurement
heights within the PDMS
gasket. The measured height
(seen here as red lines)
changed for every point.

Relative bead velocity vs % height in the cell
showing a maximum velocity around 25%, where
it is closer to the electrode providing the force.
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Relative bead velocity vs PDMS depth at a single height showing the trend
becoming less steep as the height increases because the no‐slip boundary
at the ceiling moves away and therefore resistance to fluid flow diminishes
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Plot of potential over time when a
constant current is maintained at the
electrode.
All experiments, except for those that
varied current, were done at a cathodic
current of 30 µA, which is below the
diffusion limited current. This was done
to avoid damaging the electrodes or
electrolyzing water, which would produce
bubbles and hinder the flow.
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Bead velocity vs PDMS depth at varying heights showing that the curved trend
does not change based on the measurement height.
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• The velocity of the beads does not change over time.
•There is a linear relationship between current and velocity, proving
that ion flux (j) is related to current (i).
•The solution goes around the electrodes instead of up and back
over the top. The four circulations are attractive for mixing on a
small scale.
•The velocity of the beads varies through the height of the solution,
reaching a peak at around 25%.
•Deeper cells have higher velocities because the no slip boundaries
at the walls are further away, so resistance to flow is lessened.
•These results add to the fluid manipulation toolkit that MHD has to
offer.

is the same regardless of
PDMS depth.

Bead velocity at varying currents in varying PDMS depths showing that the
curved trend does not change based on differing currents.

Result:
The velocity changes both as a function of the vertical location in the cell, and the depth of the cell. This is
consistent with studies done in the perpendicular magnetic field.
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Configuration and Geometry of the RWALP15 Transmembrane Peptide
in a Lipid Bilayer
Jared O. Kafader, Nicholas Gleason, and Roger E. Koeppe II
Department of Chemistry and Biochemistry, University of Arkansas, Fayetteville, AR, 72701
Abstract

Mass Spectrometry

2H

Mass spectrometry confirmed that the peptide produced during the
solid-phase peptide synthesis was in fact the RWALP15 peptide plus
the mass of the deuterium labels.
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The HPLC results confirmed that RWALP15 was present in large
quantities, but was further purified to remove impurities.
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The fluorescence data indicates that Trp residues in RWALP15 are likely
found at the membrane interfacial region in all DLPC, DMPC, and DOPC
bilayers. This suggests a transmembrane orientation, but would require
confirmation.
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• Shorten the hydrophobic core of the RWALP15 peptide. A leucine
and/or alanine would be removed to produce RWALP13 in order to
determine if the sequence is short enough to not span the lipid
bilayer.
• Removal of arginine residues in RWALP15 leaving only the
tryptophan as anchors.
• Antimicrobial assay tests can be performed on these peptides to
observe if they possess any antimicrobial activity.
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• RWALP15 in DLPC, DMPC, and DOPC has defined orientations in
or on the respective lipid bilayer.

• There is a decrease in α-helical content for RWALP15 in DLPC and
DOPC lipids.
• It is unusual that fluorescence data for DOPC to have data points
between those of DLPC and DMPC when DOPC has the thickest
membrane.
• 2H solid state NMR splitting have been obtained in DOPC,
establishing the speculation that RWALP15 might be transmembrane
in this specific lipid.

β = 90º
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All oriented samples were first analyzed with 31P NMR to ensure a well
oriented bilayer before running 2H NMR experiments. At β = 0º an aligned
sample should have a single peak around 25 ppm and at β = 90º the
aligned sample should have a peak around -25 ppm.
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The CD results illustrated that RWALP15 resides in a α-helix
configuration in all lipids. But a much smaller amount of helical character
exists in DOPC, the longest of the lipids.
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Circular Dichroism and Fluorescence
Each peptide synthesized had two corresponding deuterium labels, with one label
being 50% and the other 100%. With deuterium labels are at these specific ratios,
it is generally possible to match the labels with their corresponding intensities.

10

4

25

T im e ( m in )

Ala - 9 - 50%

Labeling

20

14

0 .2

T im e (M in )

with underlined residue being deuterated

R W A L P 1 5 in D M P C

16

0 .3

0 .0

0

R W A L P 1 5 in D L P C
18

0 .4

q, kHz

5

q, kHz

0

Intensity (280 nm)

The experimental data (shown with dots) was collected through 2H solidstate NMR and best fit according to the ∆q equation. A best fit curve is
shown with the solid line.
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RWALP15 Model
Ac-GRWLALALALALWRA-amide

A lipid/peptide mixture was mixed and then put under a vacuum line for 48 hours
(a). The peptide/lipid mixture was then placed evenly on 40 glass slides (b). The
glass plates were hydrated, placed in a cuvette, and sealed (c). The cuvette was
then heated at 40º C in a dark area for at least 48 hours (d). The sample, once
aligned in the bilayer, was run at both the β = 90º position (parallel position) and
the β = 0º position (perpendicular position).

NMR and GALA Theory

RWALP15 was placed in the lipids DLPC, DMPC, and DOPC, which have a
hydrophobic thickness of 19.5, 23, and 27 Å respectively. Distinct splittings
were seen in every DLPC, DMPC, and DOPC, implying that RWALP15 has
defined orientations in all lipids. Side chain hydrogens are represented by
strong peaks, with backbone hydrogens visible as well.

1722.1 + 8 Deuterium

Intensity (280 nm)

Membrane proteins along with their fundamental peptide-lipid interactions
are some of the least understood areas of biochemistry. To answer some
of these questions, RWALP15, a short model transmembrane peptide, was
synthesized with isotopically labeled residues through solid-phase peptide
synthesis and analyzed with 2H solid-state NMR in various lipid membrane
environments such as DLPC (C12:0), DMPC (C14:0), and DOPC
(C18:1∆9c). The Geometric Analysis of Labeled Alanines (GALA) method
was used to determine the orientation of RWALP15 in each lipid bilayer.
Synthesis confirmation of RWALP15 was determined through MALDI-TOF
mass spectrometry and peptide purification was performed by HPLC. The
results procured from the NMR tests state that the RWALP15 peptide does
in fact have a defined orientation in each of the DLPC, DMPC, and DOPC
lipid bilayers. It has been observed that the RWALP15 peptide does
contain an α-helix structure in each lipid system, though immensely
diminished in DOPC. Fluorescence data suggests that the anchoring
tryptophans in all DMPC, DLPC, and DOPC lipids are located around the
lipid/water interface. The observed quadrupolar splittings from 2H NMR
along with the GALA analysis indicate the tilt of RWALP15 to be ~7˚ in
DLPC and DMPC bilayers. It is surprising to observe a transmembrane
orientation of the RWALP15 peptide in DMPC considering its hydrophobic
length to be significantly shorter than the bilayer thickness.
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Degradation of GDP to form Apo Cdc42 wt.
Erika Russell1,2, Paul Adams2
1. Bethune-Cookman University , Chemistry Department
2. Department of Chemistry and Biochemistry, University of Arkansas

Degradation of Mant-GDP by Alkaline Phosphatase
The goal of the summer research project was to examine possible new ways to
liberate GDP from the protein of interest Cdc42Hs. With apo-Cdc42Hs, there will be a better
understanding of the structure of Cdc42Hs which could potentially reveal insights on GDP
dissociations and how this leads to cell proliferation.
Figure 6 (right): Alkaline Phosphatase
was added to Mant-GDP buffer. The
reaction was observed over 2 hour
period of time—taking readings
(200μM of Mant-GDP buffer and
800μM buffer) every 20 minutes using
the fluorometer. The intensity decreases
as GDP is degraded by Alkaline
Phosphatase.

Cdc42 wt has 178 amino acids and is one of the first identified human oncogenic proteins—mutants
of Cdc42 wt account for nearly 30% of all cancer cells(3) . The Ras family is a group of related proteins
that are involved in cellular signal transduction. As a member of the Ras family of GTP-binding proteins
Cdc42 wt aids in cellular transformation and cell growth via increased rates of GTP to GDP cycling(5).
When Cdc42 wt is bound to GTP it is active and will remain in this state until a GTP-ase activating
protein causes it to hydrolyze the phosphate group body to an inactive GDP state. To return to the active
state Guanine nucleotide exchange factors (GEFs) catalyze the exchange for bound GDP to GTP. This is
significant because a regulatory protein, dbl, has the ability to stimulate the exchange for GDP to GTP in
Cdc42 wt either by increasing the rate of cycling between GTP and GDP, or by a deficiency in GTPase
activity which can lead to cell proliferation and transformation. Additionally, Cdc42 wt has a high affinity
for dbl when it is in a nucleotide free state—thus the goal of the summer research project is determine new
ways to liberate GDP from Cdc42 wt in order to begin to study the molecular details of this form of the
protein. One of the new approaches included the potential exploitation of a chromatographic matrix with
an affinity for proteins with a well-defined nucleotide binding site.
.
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Dialyze

GDP + Unfolded Cdc42Hs
Refold Cdc42Hs
Apo-Cdc42Hs

400

420

440
460
480
Wavelength (in nm)

500

520

Figure 7 (left) is a continuation of figure 6.
Here ΔF is the change in fluorescence
relative to the initial fluorescence, where
the initial value is the 10 minute reading
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Figure 3: Gel electrophoresis confirmed pure Cdc42 wt. The samples were
collected from the fractions that correspond to the peak in figure 2.
In Figure 6, for the first 50 minutes the intensity steadily decreases starting at 60,000
and dropping to 25,000—after 50 minutes the intensity fluctuates indicating that GDP was
completely degraded after about 50 minutes . However, we were unable to repeat
experiments to establish a trend in the potential noise after 50 minutes or if another excited
state process was being exploited from an emission stand point. From this information
there is reason to believe that because Alkaline Phosphatase degrades the fluorescent
analogue of GDP then it should also degrade bound GDP in Cdc42Hs.
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Two different experiments were attempted to try to accomplish the same goal, the generation of apo-Cdc42Hs. A flow
chart diagram of what we wanted to accomplish can be seen below.
I. Experiment 1
II. Experiment
A. Control Experiment
A. Control
1. Control protein Pyruvate Kinase + Cibracon Sepharose
1. Mant-GDP +Buffer (64mM Tris-HCl, pH 7.6,
Pyruvate Kinase-Cibracon Sepharose
1mM EDTA, .5mM DTE, 1mM NaN3)

40000

1.2

Figure 2: Chromatograph of purified Cdc42Hs wt.

Kda

Figure 1: Cdc42Hs-GDP(4)

Intensity

60000

Purify

Pure GDP-Cdc42Hs
GTP + Buffer( 32mM Tris-HCl, 200mM (NH4)2SO4
.5mM NaN3, pH 8) + Alkaline Phosphatase

Figure 3: Structure of Cibracon Blue covalently attached to the matrix(6)

GTP-Cdc42Hs + guanosine
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Phosphodierterase
Cdc42Hs
Sample Fractions
were collected

Cibracon-Sepharose
In Experiment 1, the goal was to unfold Cdc42Hs using a buffer containing Urea, and to refold without GDP. To begin
parameters were established using a control proteins Pyruvate Kinase and a Cibracon-Sepharose Column. The protein was
selected because it possesses a dinucleotide fold and because of this it should bind well to the Cibracon blue dye. This is believed
because Cibracon Blue dye is covalently attached to the Sepharose matrix, and can be used to have a greater affinity for the
binding sites of proteins with a dinucleotide fold like Pyruvate Kinase and Glutamine Synthetase. This is important to try because
if it works then we can also try to bind Cdc42 wt to exploit potential binding affinity of Cibracon Blue.
In Experiment 2, to create apo-Cdc42Hs. GDP was exchanged for GMPPCP. Alkaline Phosphatase reduced GDP to
guanosine, (which can be monitored on the FPLC) and after a full GDP-GMPPCP exchange is believed to have occurred
phosphodiesterase will be added to degrade GMPPCP and leaving Cdc42Hs nucleotide free. Subsequently, Cdc42Hs can then be
added to the Cibracon-Sepharose column.
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NaCl was added
Figure 4: Chromatograph of Pyruvate Kinase from Cibracon
Sepharose column Sample fractions were collected and tested
using gel electrophoresis, however we did not see any bands at
25Kda (molecular weight of pyruvate kinase) so we could not
confirm that this is the protein, however, some experimental error
could be involved.

6. Lowe, C.R.; Pearson, J.C. Affinity
Chromatography on immobilized dyes.
Methods Enzymol 1984,104, 97–113.

A Kinetic Study of Cytochrome c and Cytochrome c Oxidase
Maria Willaims Texas Southern University, Houston, Texas
Dr. Lois Geren, Marilyn Davis , Dr. Francis Millett, & Dr. Jeffrey Havens, University of Arkansas, Fayetteville

Introduction
Electron-transfer reactions play an essential role in a biological processes such
as mitochondrial respiration. Cytochrome c and cytochrome c oxidase are two
major components of the electron transport system.

Discussion
Experimental Procedures
The mutants that were used in the experiment are labeled as E89T/E90Q and E89T/E90K. The mutants
were expressed in XL21BE3 native E.coli cells using plasmid DNA strands with the selected mutations
which will grow and express. The mutants were expressed in rich broth for a forty-eight hour period and
were spun down in the centrifuge to get the protein into solution. Once all of the rich broth is gone the cells
were lysed and the protein purified. The purification process included ammonium sulfate precepitation,
size exclusion chromatography, and high pressure liquid chromatography (HPLC) using a cation exchange
column. The protein was highly pure after the HPLC. The protein still had a high concentration of salt, so it
was exchanged with 5 mM sodium phosphate pH 7, using a centrifuge concentrator. The protein was then
used for the kinetic studies. The kinetics were started by measuring out .08705 grams of sodium dithionite
and 5 milliliters of water to make .1M of solution which is made anaerobic. The stock solution of oxidase
was diluted by a 1:100 ratio, so 3 uL of oxidase was diluted with 300 uL of buffer. The buffer was 5 mM
PI/100 mM NaCl .01% LM pH 7 at 25 C. For each experiment, a concentration of cytochrome c was placed
in 500 uL of buffer and degassed. The concentration was then measured on the degassed sample and on
average 3 to 5 uL of sodium dithionite was added to the sample to fully reduce cytochrome c. The spectra
was checked again to see if cytochrome c was fully reduced. Once this had happened, the top is opened to
check to see if the spectra remained stable. Then the required amount of oxidase was added to the sample
and the rate of oxidation of cytochrome c was measured at 550 nm in the spectrometer. This was repeated
many times to obtain data for the experiment.

The goal of our experiments was to determine the effect of replacing the native negative
charge of the glutamic acid [E] of position 90 of cytochrome c with a neutral charge, glutamine
[Q] and a positive charge lysine, [K]. The E98T/E90Q mutant expressed well and that allowed us
to collect a large amount of protein for kinetic experiments. The E89T/E90K mutant did not
express well but we did obtain enough for the kinetic experiments.
The reaction of cytochrome c with cytochrome oxidase obeyed first-order kinetics at all
concentration of cytochrome c. The results of my experiments were that at lower cytochrome c
concentration, the first-order rate constant was larger, and at higher cytochrome c concentration
the rate constant became smaller. The experiments were conducted on two days consecutive days.
Over the two day period we were able to gather data to plot on graphs but the 07/16 E89T/E90Q
data was too scattered to plot. The objective in plotting the points is a trend line to get values for
the Vmax .
In summary, the Vmax of both the E89T/E90Q and E89T/E90K mutants was smaller than
that of wild-type cytochrome c, indicating that residue 90 plays a role in the interaction between
cytochrome c and cytochrome oxidase.

Conclusion
The Vmax for both the E89T/E90Q and E89T/E90K mutants are
smaller that of the Human cytochrome c wild type. The E89T/E90Q mutant
values is faster than the E89T/E90K due to faster reaction rates.

Results
The basis of my experiment is to study the reaction of cytochrome c with cytochrome oxidase using sitedirected mutagenesis and steady-state kinetics. The goal was to characterize the electrostatic interaction
between cytochrome c and cytochrome oxidase. The mutants that were expressed in this project were
E89T/E90K and E89T/E90Q. These mutants replace the native negative charge on glutamic acid 90 [E90] of
with a neutral charge, glutamine [Q], or a positive charge, lysine [K]. By gathering data from the kinetic
experiments, we will be able to determine if the mutations had an effect on the reaction between cytochrome
c and cytochrome c oxidase. Steady-state kinetics reactions generally display saturation kinetics at
sufficiently high cytochrome c concentrations and often obey Michaelis-Menten kinetics with a Michaelis
constant, Km, and a maximum velocity, Vmax.
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